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Abstract
The microorganisms on and in the human body play a significant role in health and disease; however, little is
known about how the interactions between these complex communities affect our wellbeing. This study
examines how bacteria and phage interact through bacterial nucleases that restrict infection, such as restriction
enzymes and CRISPR systems, and the covalent DNA modifications that neutralize them. Multiple targeted
nucleases equip bacteria with an innate immune response against phage, and CRISPR systems provide an
adaptive immune response. I report three main studies. 1) To study the human gut microbiome and virome
(comprised predominately of phage), we collected fecal samples from a healthy individual over four years.
From the fecal samples, total bacterial DNA and DNA from purified virus like particles (VLPs) were
sequenced using Illumina and Pacific Bioscience single-molecule real-time (SMRT) sequencing to yield
information about genome sequences and covalent modifications. Using computational methods we
identified seven bacterial contigs and one phage contig with CRISPR arrays targeting phage contigs. This
suggests that both bacteria and phage use CRISPR systems to compete with other phage. 2) Covalent DNA
modifications are known to block the nuclease activity of restriction enzymes, however it was unknown if they
can block the nuclease activity of CRISPR systems. To address this, we test if the CRISPR-Cas9 system could
target wild type T4 phage and two T4 mutants. Wild type T4 modifies all its cytosines to glycosylated
hydroxymethylcytosine (glc-HMC), and the two mutant T4 phage contain either hydroxymethylcytosine
(HMC) or unmodified cystosines (C). These tests confirmed that glc-HMC and HMC in high concentrations
can block CRISPR-Cas9. 3) To explore interactions between bacteria and phage further, we used covalent
DNA modification data to link bacteria and phage pairs from the human gut microbiome, based on the idea
that phage and bacterial DNAs in the same cell have been exposed to the same DNA modifying enzymes and
thus share modification patterns. Overall, 443 modified motifs were shared between phage and bacteria,
suggesting many possible phage-host pairs. In our data, 73% of phage genomes and 56% of bacterial genomes
contained motifs that were completely modified, highlighting how ubiquitous and important the roll of DNA
modifications are. These data allowed us to begin to specify the extent and types of interactions between
phage and bacteria in longitudinal data. This work explores the complex interactions between bacteria and
phage, a crucial step in understanding how these organisms contribute to human health and disease.
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ABSTRACT 
 COVALENT DNA MODIFICATIONS IN PHAGE AND BACTERIAL DYNAMICS  
Alexandra Lynn Bryson 
Dr. Frederic Bushman’s Laboratory 
The microorganisms on and in the human body play a significant role in 
health and disease; however, little is known about how the interactions between 
these complex communities affect our wellbeing.  This study examines how 
bacteria and phage interact through bacterial nucleases that restrict infection, 
such as restriction enzymes and CRISPR systems, and the covalent DNA 
modifications that neutralize them.  Multiple targeted nucleases equip bacteria 
with an innate immune response against phage, and CRISPR systems provide 
an adaptive immune response.   I report three main studies.  1) To study the 
human gut microbiome and virome (comprised predominately of phage), we 
collected fecal samples from a healthy individual over four years. From the fecal 
samples, total bacterial DNA and DNA from purified virus like particles (VLPs) 
were sequenced using Illumina and Pacific Bioscience single-molecule real-time 
(SMRT) sequencing to yield information about genome sequences and covalent 
modifications.  Using computational methods we identified seven bacterial 
contigs and one phage contig with CRISPR arrays targeting phage contigs. This 
suggests that both bacteria and phage use CRISPR systems to compete with 
other phage.  2) Covalent DNA modifications are known to block the nuclease 
activity of restriction enzymes, however it was unknown if they can block the 
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nuclease activity of CRISPR systems.  To address this, we test if the CRISPR-
Cas9 system could target wild type T4 phage and two T4 mutants. Wild type T4 
modifies all its cytosines to glycosylated hydroxymethylcytosine (glc-HMC), and 
the two mutant T4 phage contain either hydroxymethylcytosine (HMC) or 
unmodified cystosines (C).  These tests confirmed that glc-HMC and HMC in 
high concentrations can block CRISPR-Cas9.  3) To explore interactions 
between bacteria and phage further, we used covalent DNA modification data to 
link bacteria and phage pairs from the human gut microbiome, based on the idea 
that phage and bacterial DNAs in the same cell have been exposed to the same 
DNA modifying enzymes and thus share modification patterns.  Overall, 443 
modified motifs were shared between phage and bacteria, suggesting many 
possible phage-host pairs.  In our data, 73% of phage genomes and 56% of 
bacterial genomes contained motifs that were completely modified, highlighting 
how ubiquitous and important the roll of DNA modifications are.  These data 
allowed us to begin to specify the extent and types of interactions between phage 
and bacteria in longitudinal data. This work explores the complex interactions 
between bacteria and phage, a crucial step in understanding how these 
organisms contribute to human health and disease. 
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 Chapter 1: Introduction 
1.1 The human gut virome and microbiome 
The microorganisms on and in the human body play a significant role in 
health and disease.  Commensal microbes help our immune systems develop 
properly, aid us in the breakdown and digestion of nutrients, and guard against 
pathogen invasion(1-5).  However, dysbiosis (disease associated with microbial 
ecosystem shifts) among the microbiota has been linked to heart disease, 
inflammatory bowel disease, depression, autoimmune disease, and obesity(6-
17). 
The human gastrointestinal tract contains one of the most densely populated 
microbial communities in the human body, and recent advances in deep 
sequencing technologies reveal complex communities of bacteria and viruses 
living and interacting together.  Phage, in addition to being the vast majority of 
viruses detected within the human gut, are also the most prevalent biological 
entities on Earth (estimated at 1031 virions) and known to dynamically regulate 
bacterial populations(2-5, 18-20).  Studies of phage, since their independent 
discovery in the early 1910s by Twort and d’Herelle, helped establish 
fundamental principals in molecular biology and genetics(21, 22); however, once 
the groundwork was laid, those fields quickly transitioned to studying higher order 
model organisms.  The recognition that phage play an integral role in the healthy 
1
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human microbiome has brought about a recent resurgence of phage biology in 
the context of the human virome. 
The human gut virome can be studied by isolating virus like particles (VLPs) 
from fecal samples.  Fecal samples offer a non-invasive way to study microbiota 
of the lower gastrointestinal tract.  Fecal samples are homogenized, passed 
though a 0.2µm filter (to remove human and bacterial cells) then treated with 
DNAse and RNAse to remove DNA that is not contained in a VLP.  The VLPs are 
then broken down with proteinase K and their nucleic acids are extracted for 
sequencing.  The sequenced viral genomes are assembled de novo using 
computational methods.  These proposed genomes are referred to as contigs.  
RNA and DNA viruses known to infect human cells have been found using these 
methods, however the majority of isolated viruses are DNA phage.  RNA viruses 
found in healthy, fecal samples are typically plant pathogens, which are thought 
to have been ingested with food and are passing though transiently(23). 
 To study bacteria of the human gut, total DNA is extracted from fecal 
samples.  The DNA can then be prepared and sequenced using two different 
methods.  The first is shotgun metagenomics, where the total, extracted DNA is 
sequenced using high-throughput technology.  The resulting sequencing reads 
are filtered to remove those mapping to the human genome.  The remaining 
sequence reads are assembled de novo using computational methods.  Roughly 
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96% of resulting contigs belong to bacteria, with the remaining 4% belonging to 
phage.  The second method is 16S ribosomal DNA (16S rDNA) amplicon 
sequencing.  The gene encoding 16S ribosomal RNA is ubiquitous and highly 
conserved among bacteria.  The 16S rDNA also contains nine hyper-variable 
regions that can be used to distinguish between bacterial species. Primers 
targeting the conserved segments of the 16s rDNA are used to amplify the gene.  
These amplicons are sequenced and the variable regions they contain are used 
to determine which bacteria are present within a fecal sample. 
Understanding the dynamics between bacteria and phage in healthy 
individuals is a crucial step in learning to treat disorders involving a dysbiotic 
microbial communities. However determining which phage infect which bacteria 
is a difficult challenge.  The human gut provides a unique niche for bacteria and 
phage to coexist that has yet to be replicated in a laboratory setting.  Previous 
efforts have failed to grow gut phage in vitro (outside of gut) despite being able to 
observe the phage propagating within a gnotobiotic mouse gut(24). Matching 
phage-host pairs is further complicated because phage can sometimes infect 
multiple bacterial hosts. Traditionally, there have been many phage known to 
bind a specific receptor, and they do not bind other structures that vary only 
slightly from their host receptor.  Research done by Jensen et al. suggests that 
current methods of isolating phage artificially select for phage with a specific host 
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and that phage with a broad-range of hosts are more prevalent than previously 
thought(25).  Jansen et al. even identified phage that plaque on both Escherichia 
coli and Sphaerotilus natans, which belong to different classes, 
Gammaproteobaceria and Betaproteobacteria respectively(25).  
In this body of work we seek to identity phage/ bacterial-hosts pairs and 
understand how they interact, particularly through host-parasite competition 
based on nucleases and protection of DNA with covalent modifications. 
 
1.2 Phage influence on bacterial communities 
There are two major mechanisms by which phage influence the survival of 
bacterial communities.  Phage can exert a predatory pressure killing their host or 
providing advantageous genetic information though lateral gene transfer.  Most of 
what is known about the control of bacterial populations by phage comes from 
environmental studies, particularly in lakes and seawater(26-31). The literature 
indicates that dynamics between phage and bacteria including predation rates 
can vary significantly.  Work done in Germany’s Lake Plussee demonstrated that 
bacterial mortality from viral lysis varies within the same body of water based on 
the steep temperature and oxygen gradients of the lake.  In the warm and oxic 
epilimnion, 8% to 42% of bacterial deaths are attributed to viral lysis, whereas in 
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the cooler, anoxic hypolimnion 88% to 94% of bacterial mortality is attributed to 
viral lysis(28).   
Phage can provide survival advantages to their bacterial hosts by existing in 
a lysogenic state as a prophage or episome.  Research conducted on bacteria 
living in the gulf of Mexico suggests that 0.07% to 4.4% of the bacteria harbor a 
prophage(27).  Other studies suggest higher rates of lysogenized bacteria in 
different environments (32).  A filamentous phage, f327, is though to help 
Pseudoalteromonas survive in the Artic Sea by enhancing motility and 
chemotaxis of their host(32).  Other marine phage provide their hosts with genes 
to carry out carbon and phosphate metabolism as well as photosynthesis(33, 34).   
Phage are also known to transfer antibiotic resistance genes between 
bacteria(35).  The mobility of antibiotic resistance is of particular concern to heath 
care providers as multidrug resistant pathogens are become more prevalent. 
 
1.3  Restriction-Modification Systems  
Bacteria use restriction-modification systems to protect themselves from 
foreign DNA, such as the DNA injected by a phage.  To distinguish self from non-
self DNA, bacteria use enzymes to add covalent modifications to their own 
genomes at specific nucleotide motifs known as recognition sites.  The number of 
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nucleotides in a recognition site is typically 4 to 8 bases, and the exact motif 
sequences vary among restriction/modification systems.  Restriction enzymes 
scan DNA for recognition sites. If a recognition site is unmodified the restriction 
enzyme binds to the motif and cleaves the DNA.  If the recognition site is 
modified, the restriction enzyme will not be able to bind and cleave the DNA due 
to steric hindrance.  The first evidence for restriction-modification systems arose 
in the 1950s from work done by Salvador Luria and Giuseppe Bertani when they 
found phage λ could grow on some E. coli strains but not others(36, 37). In the 
1960s Werner Arber and Matthew Meselson demonstrated this restriction of 
phage growth was caused by enzymatic cleavage (38-40).  
Restriction enzymes are traditionally classified into four types. Type I 
enzymes (originally discovered to target phage λ) contain multiple subunits that 
preform restriction-and-modification functions within in one enzyme.  Their 
restriction cut sites are random and distant from the recognition motif.  Type II 
restriction enzymes cut at defined positions close to or within a specific DNA 
sequence motif.  HindII was the first Type II restriction enzyme to be 
characterized, when in 1970, Hamilton Smith observed phage P22 DNA 
degrading in the presence of Haemophilus influenza cell extract (41, 42).  Type 
III enzymes are combination restriction-and-modification complexes that cleave 
outside of their recognition sequence and required two motifs in opposite 
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orientations.  In contrast to Types I-III, Type IV enzymes recognize and cleave 
modified (typically methylated) DNA such as McrBC in E. coli. 
Phage evolved to avoid restriction modification systems by 
commandeering their host’s modifying enzymes or alternatively by encoding their 
own.  Replicating phage are thereby exposed to the same modifying enzymes as 
their host and are likely to share modification patterns.  In this work, we 
hypothesize that phage and their hosts can be linked matching DNA modification 
patterns between the two.  
1.4  CRISPR 
The Clustered regularly interspaced short palindromic repeats (CRISPR) and 
CRISPR-associated (Cas) proteins form an adaptive immune system used by 
roughly 50% of bacteria to confer resistance against phage, plasmid-mediated 
lateral gene transfer, and other mobile genetic elements (MGE)(43, 44).  The 
CRISPR-Cas system allows for acquisition and storage/memory of phage and 
plasmid-derived sequences that can be used to identify future infections based 
on sequence homology.  The CRISPR locus is comprised of an AT-rich leader 
sequence followed by an array of uniform repeat sequences alternating with 
unique segments of viral or MGE sequences (spacers).  The spacers, averaging 
32bp in length, are acquired from an invading virus or plasmid and integrated into 
the CRISPR locus near the 5’ leader end creating a linear history of invading 
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DNA.  The region in the viral or plasmid genome that matches the spacer is 
referred to as the protospacer(45).   
Upstream of the CRISPR array lies the Cas genes.  Different organisms 
contain distinctive clusters of Cas genes, which fall into two major classes that 
can be further broken down into five types and sixteen subtypes(46, 47).  
CRISPR systems requiring multiple proteins for interference belong to class I, 
while CRISPR systems requiring only one protein for interference are a part of 
class II.  Cas proteins process transcribed CRISPR arrays into smaller fragments 
called CRISPR RNAs (crRNA).  Cas proteins in complex with a crRNA form a 
functional unit that base pairs with and cleaves DNA containing the homologous 
protospacer sequence and a specific protospacer-adjacent motif (PAM) of ~3-7 
bases(45, 48, 49).  The PAM sequence plays an important role in allowing the 
CRISPR system to distinguish between self and non-self DNA.  The absence of 
PAMs in CRISPR arrays prevents the CRISPR system from degrading its own 
DNA. 
Two modes of spacer acquisition have been reported for class I CRISPR 
systems: native and primed(50-57).  So far, only native spacer acquisition has 
been reported in class II CRISPR systems(58-61).  In native spacer acquisition, 
proteins Cas1 and Cas2 are necessary and sufficient to obtain new spacers from 
foreign DNA.  Primed spacer acquisition requires Cas1, Cas2, Cas3, Cascade (a 
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complex of Cas proteins) and a “priming” spacer targeting an existing 
protospacer.  Priming enhances spacer acquisition 10 to 20 fold compared to 
native acquisition(62).  Spacer acquisition through priming increases when the 
priming spacer is an imperfect match to the protospacer or when the protospacer 
does not have the correct PAM(62).  This is thought to counteract against phage 
acquiring point mutations to escape the sequence homology requirements of 
CRISPR targeting. 
The class II, type II systems are among the best-characterized CRISPR 
systems largely because of their simple four Cas gene structure (Cas9, Cas1, 
Cas2, and Csn2 or Cas4).  Cas9 is the signature gene within these systems.  
The Cas9 protein aids in crRNA biogenesis and cleavage of target DNA. These 
systems also require a trans-activating crRNA (tracrRNA)(63).  In crRNA 
biogenesis, the tracrRNA hybridizes with the transcribed CRISPR array forming 
dsRNA that is then cleaved by RNase III (a bacterial host enzyme) to release the 
individual crRNAs.  Cas9, the crRNA, and the tracrRNA then together form a 
functional unit to cleave target DNA.  Cas9 has an HNH domain and a RuvC-like 
domain, which cleave protospacer targets that match the crRNA(63). 
Phage use several mechanisms to evade CRISPR systems. Point mutations 
acquired in the PAM or protospacer sequences allow phage to escape the 
sequence homology requirement of CRISPR systems.  Exact homology between 
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the first eight bases of the spacer and protospacer (known as the seed 
sequence) are crucial for the CRISPR system to recognize and degrade its 
target.  Outside of the seed sequence, multiple point mutations can accumulate 
before inhibiting the CRISPR system(64).  To date, three phage encoded anti-
CRISPR (Acr) proteins have been reported: AcrF1 (from phage JBD30), AcrF2 
(from phage D3112), and AcrF3 (from phage JBD5)(64, 65).  These proteins 
block the DNA-binding activity of the CRISPR-Cas complex and bind the Cas3 
helicase-nuclease so it cannot be recruited to target DNA bound by the CRISPR-
Cas complex(65).  One study evaluated if a single adenine-N6-methyl DNA 
modification within a phage protospacer could block CRISPR activity, since 
methyl groups are known to block other nucleases(66).  The single adenine-N6-
methyl group was not sufficient to block CRISPR activity; however, phage are 
known to have multiple unique and unusual DNA modifications (many of which 
are significantly larger than methyl groups).  Thus, here we seek to determine if 
larger DNA modifications can block the CRISPR-Cas9 system.  We also search 
for CRISPR systems targeting phage within the human gut microbiome for an 
improved understanding of how the phage and bacteria communities are 
intertwined.  
 
11 
 
1.5 Covalent DNA modifications in Phage 
At least ten covalent DNA modifications have been reported in phage such as 
α-gluThy in SP10, 5-dhpUra in SP15, 5-mCyt in χP12, and 2-n-Ade in S2L(67).  
Despite the remarkable bases seen in phage, very few phage have been 
analyzed for covalent modifications, and no studies have looked at DNA 
modifications of phage in the human microbiome.  DNA modifications of bacteria 
within the human microbiome were previously evaluated in one paper yielding 
information about two Bacteroides genomes(68).  In this body of work, we 
evaluate the modification profiles of the complete microbiome, including both 
phage and bacteria, providing insight into the frequency and breadth of DNA 
modifications of the human gut microbiome.  Additionally, we demonstrate a new 
function for several different phage DNA modifications. 
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2.1 Contributions 
My contributions to this paper are the CRISPR analysis and MetaPhlan analysis.  
I generated Table 1,  Figure 5, Figure S2, and Figure S3. 
2.2 Abstract 
Humans are colonized by immense populations of viruses, which 
metagenomic analysis shows are mostly unique to each individual. To investigate 
the origin and evolution of the human gut virome, we analyzed the viral 
community of one adult individual over 2.5 y by extremely deep metagenomic 
sequencing (56 billion bases of purified viral sequence from 24 longitudinal fecal 
samples). After assembly, 478 well-determined contigs could be identified, which 
are inferred to correspond mostly to previously unstudied bacteriophage 
genomes. Fully 80% of these types persisted throughout the duration of the 2.5-y 
study, indicating long-term global stability. Mechanisms of base substitution, 
rates of accumulation, and the amount of variation varied among viral types. 
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Temperate phages showed relatively lower mutation rates, consistent with 
replication by accurate bacterial DNA polymerases in the integrated prophage 
state. In contrast, Microviridae, which are lytic bacteriophages with single-
stranded circular DNA genomes, showed high substitution rates (>10(-5) per 
nucleotide each day), so that sequence divergence over the 2.5-y period studied 
approached values sufficient to distinguish new viral species. Longitudinal 
changes also were associated with diversity-generating retroelements and virus-
encoded Clustered Regularly Interspaced Short Palindromic Repeats arrays. We 
infer that the extreme interpersonal diversity of human gut viruses derives from 
two sources, persistence of a small portion of the global virome within the gut of 
each individual and rapid evolution of some long-term virome members. 
2.3 Introduction 
There are an estimated 1031 viral particles on earth, and human feces 
contain at least 109 virus-like particles per gram (1–3). Many of these are 
identifiable as viruses that infect bacteria (bacteriophages), but the great majority 
remains unidentified. Even today, gut virome samples taken from different human 
individuals still yield mostly novel viruses (4–8), and only a small minority of viral 
ORFs resembles previously studied genes (7). Bacteriophages are of biomedical 
importance because of their ability to transmit genes to their bacterial hosts, 
thereby conferring increased pathogenicity, antibiotic resistance, and perhaps 
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new metabolic capacity (4, 5, 9, 10). Despite their importance, the forces 
diversifying bacteriophage genomes in human hosts have not been studied in 
detail. Humans show considerable individual variation in the bacterial lineages 
present in their guts (11–13); this variation likely is one reason for the differences 
in their phage predators (5–8, 14). The large differences in phage populations 
among individuals also may be influenced by within individual viral evolution. To 
investigate the origin and nature of human viral populations, we carried out a 
detailed study of a single human gut viral community. Ultra-deep longitudinal 
analysis of DNA sequences from the viral community, combined with 
characterization of the host bacteria, revealed rapid change over time and begins 
to specify some of the mechanisms involved. 
 
2.4 Results 
2.4.1 Sample Collection, Viral Purification, and DNA Sequencing.  
Stool samples (n = 24) were collected from a healthy male at 16 time 
points spread over 884 days (Fig. 1A). For eight of the time points, two separate 
samples taken 1 cm apart were purified and sequenced independently to allow 
estimation of within-time point sample variation. Virus-like particles were 
extracted by sequential filtration, Centricon ultrafiltration, nuclease treatment, and 
solvent extraction. Purified viral DNA was subjected to linear amplification using 
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Φ29 DNA polymerase, after which quantitative PCR showed that bacterial 16S 
sequences were reduced to less than 10 copies per nanogram of DNA, and 
human sequences were reduced to below 0.1 copies per nanogram, the limit of 
detection. Paired-end reads then were acquired using Illumina HiSeq 
sequencing, yielding more than 573 million reads (Q ≥ 35; mean read length, 
97.5 bp), with 15–39 million reads per sample (Table S1). No attempt was made 
to study gut RNA viruses, which also are known to exist, although some samples 
were dominated by abundant plant RNA viruses ingested with food (15). 
Sequence reads from each sample were first assembled individually using 
MetaIDBA (16). When reads were aligned back onto contigs generated within 
each sample, only 71% of reads could be aligned. Improved contigs then were 
generated using a hybrid assembly method combining all samples, taking 
advantage of the fact that viruses that are rare at one time point may be 
abundant at another. After this step, 97.6% of the reads could be aligned to 
contigs, allowing assessment of within-contig diversity. Rarefaction (collector’s 
curve) analysis showed that the detection of these contigs was saturated at 20-
fold coverage (median, 82-fold); from the purification results, we infer these 
contigs to be mostly or entirely DNA viruses (Fig. 1C). Sixty contigs assembled 
as closed circles (ranging in size from 4–167 kb), an indication of probable 
completion of these genome sequences, providing an estimate of the viral 
population size and composition in unprecedented detail. One circular genome 
23 
 
was sequenced independently using the Sanger method and was confirmed to 
have the structure predicted from the Solexa/Illumina data (SI Methods). The 
abundance of each contig at each time point was measured by the proportion of 
reads that aligned to it, normalized to the length of each contig. The correlation 
coefficient between replicate samples from the same time point was at least 0.99, 
indicating a high degree of reproducibility (Fig. S1). 
 
2.4.2 Viral Groups Detected 
Taxonomic analysis of these contigs indicated recovery of Microviridae, 
Podoviridae, Myoviridae, and Siphoviridae, but contigs with taxonomic 
attributions were a minority, only 13%, emphasizing the enormous sequence 
variation present in bacteriophages. Microviridae (the group including ΦX174) 
predominated, but this predominance could be a consequence of favored 
amplification by Φ29 polymerase of the small circular genomes that characterize 
this group. The most abundant contigs were mostly retained over the duration of 
the experiment. Because there are many possible pairwise comparisons between 
time points, distances between time points analyzed (Fig. 2A, x-axis) were 
compared with Jaccard index values (Fig. 2A, y-axis), which score shared 
membership, over all of the possible pairwise comparisons of time points. On 
average, more than 80% of contigs were found in common between the time 
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points separated by 850 d (points at the right side of the plot), the longest time 
intervals compared. No contigs corresponded to known viruses infecting 
eukaryotic cells. To investigate the possible presence of eukaryotic cell viruses 
further, we aligned the raw sequence reads to the National Center for 
Biotechnology Information viral genome database. Thirty-two percent coverage 
was seen for Gyrovirus in one time point, and pooling reads over all time points 
yielded 42% coverage. Gyrovirus is a Circovirus genus with very small genome 
sizes (∼2.3 kb) recently reported to infect humans (17). However, the number of 
reads aligning was modest (10 total), and in no case did both reads of the paired 
end reads align. Because of these results, and in addition to the small target size, 
we believe that the detection of Gyrovirus is uncertain. All other animal cell virus 
genomes showed <10% coverage, so detection is questionable. The rarity of 
eukaryotic virus sequences is typical of gut virome samples from healthy 
individuals (4–6, 18, 19), emphasizing the tremendous size of the bacteriophage 
populations of the gut. 
2.4.3 Host Bacteria 
To allow tracking of the bacterial hosts, for three of the time points we also 
sequenced a total of 5.2 Gb of DNA purified from unfractionated stool, which 
yields predominantly bacterial DNA. Attribution of bacterial lineages using 
MetaPhlAn (20) showed members of the Bacteroides and Firmicutes phyla to be 
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the most abundant community members (Fig. S2). Bacterial community 
membership and taxonomic proportions showed only modest variation over time. 
Longitudinal Base Substitution in Viral Contigs. The depth of sequence 
information available and the quality of the viral contigs allowed a detailed 
assessment of the rates of accumulation of base substitutions. For each viral 
contig at each time point, the extent of nucleotide polymorphism was determined 
by aligning reads within each sample. The extent of nucleotide substitution then 
was compared for each contig between time points, and substitution frequencies 
were correlated with biological features. Substitution rates varied with viral family 
and replication style (Fig. 2B). The Microviridae showed the highest substitution 
rate (P < 0.004). Microviridae package ssDNA genomes, which have been 
reported to show higher mutation rates than dsDNA genomes in vitro (21, 22), 
and this study confirms this result in a human host. The Podo-, Myo-, and 
Siphoviridae all package dsDNA genomes and showed lower substitution 
frequencies. The lowest substitution rates were seen for temperate 
bacteriophage (P = 0.015, Kruskal–Wallace test), which can integrate into the 
host bacterial genome. Temperate phages were identified as contigs satisfying at 
least one of three criteria: (i) encoding integrase genes, (ii) homologs present as 
prophage in sequenced bacterial genomes, or (iii) annotated as resembling 
previously studied temperate phage (5). When integrated, temperate phage DNA 
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is replicated by high-fidelity bacterially encoded machinery, and temperate phage 
also may undergo fewer lytic replication cycles; both result in lower substitution 
rates. Temperate bacteriophage showed significantly lower substitution rates 
even when Microviridae were excluded from the comparison (P = 0.044). There 
was no significant difference in rates among the families of large dsDNA viruses. 
The four contigs with the highest rate of nucleotide substitution were all members 
of the Microviridae (Fig. 3A). The main variant for each lineage showed 1–4% 
nucleotide substitutions over the course of the experiment (more than one 
substitution per 105 nt per day). An alternative explanation for these high 
substitution rates could be the immigration of new closely related Microviridae 
into the community. To investigate this possibility, we reconstructed the 
consensus genome for the four contigs at multiple time points and aligned them 
against a large collection of Microviridae genomes. In every case the contig 
consensus sequences for all time points clustered closely together (Fig. 3B), 
arguing against immigration of related Microviridae and supporting the model of 
continuous substitution in long-term viral residents. A detailed analysis of the 
longitudinal change of each SNP detected (Fig. 4) showed that a complex 
community of variants was present at most time points and that new SNPs 
accumulated on this background. Substitutions could accumulate either at a 
steady rate or in an episodic fashion, for example in response to a change in 
selective pressure. Linear modeling of substitution rates versus time showed 
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correlation coefficients of 0.91–0.99, consistent with generally steady substitution 
rates, although with considerable sample-specific fluctuations. Longitudinal 
sequence divergence in major variants predicted from the Illumina data were 
confirmed using Sanger sequencing for two of the Microviridae (described in SI 
Methods). 
2.4.4 Clustered Regularly Interspaced Short Palindromic Repeats Targeting 
Phage Genomes 
One force driving phage sequence variation is the bacterial Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR) system (23–26). 
DNA sequences from invaders such as bacteriophage or plasmids are 
incorporated as spacers into arrays in the bacterial genome. Transcription of 
such arrays allows the CRISPR spacer RNAs to be incorporated into 
nucleoprotein effector complexes that target the destruction of sequence-
complementary invaders. Thus, bacteriophages are under pressure to mutate to 
evade degradation by the CRISPR system, as has been documented in model 
systems (23–25, 27). The deep analysis of viral sequences presented here, 
together with the shotgun metagenomic analysis of host bacterial sequences, 
allowed the influence of the CRISPR system in vivo to be studied in detail. A total 
of 34 types of CRISPR repeat sequences and their associated spacers were 
identified in the bacterial metagenomic sequence. Table 1 shows that several of 
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these spacers targeted contigs from the virome sequence data. Up to 28 spacers 
could be identified targeting a single viral contig. The CRISPR-targeted viral 
contigs were analyzed for their relative abundance over time. No simple pattern 
was seen relating the presence of CRISPR spacers to the relative abundance 
over all of the targeted viruses. In one case, a viral contig accumulated a base 
substitution in a CRISPR target site, and the mutant contig increased in 
abundance while the original contig declined, suggestive of CRISPR evasion by 
mutation (Fig. S3). Of the CRISPR arrays identified, four appeared to be 
encoded by temperate phage. Several previous reports also have documented 
phage-encoded CRISPR arrays (5, 28, 29). An analysis of longitudinal variation 
in phage CRISPR arrays would be useful, but uncertainties in reconstructing 
arrays from short read data precluded a detailed analysis. For the CRISPR array 
with the most sequence coverage (contig 117), we found that the entire collection 
of spacers was replaced over the time series studied. The phage-encoded 
CRISPR array on phage contig 117 encoded spacers that targeted four different 
phage contigs from our study (Fig. 5 shows one example). We previously 
reported another example from a different subject of a phage-encoded CRISPR 
spacer targeting a different phage in the same virome sample (5). Evidently 
phages commonly use CRISPR systems to compete with one another. 
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2.4.5 Identifying Phage Hosts 
Characterization of bacteriophage populations by sequencing typically 
does not specify the host bacterial species, leaving important gaps in our 
understanding of phage–host interactions. Analysis of CRISPRs, however, 
provides a means of connecting phage–host pairs (Table 1). Three previously 
sequenced bacterial genomes, from Ruminococcus bromii, Eubacterium 
siraeum, and Bacteriodes fragilis, contain CRISPR repeats that were found here 
linked to spacers matching virome contigs from this study (contig 232_308, 
contig 132_57, and contig 111_52, respectively), allowing us to infer that these 
phages infect these three bacteria in the subject studied. In another approach to 
associating phage–host pairs, phage sequences annotated as integrated 
prophages in sequenced bacterial genomes could be recognized that resembled 
our newly sequenced phage contigs, thereby also specifying potential hosts (4–
6). Bacterial lineages identified as harboring phage from the virome analysis 
included Bacteroides fragilis, Eubacterium siraeum, Ruminococcus bromii, 
Blautia hansenii, and Lachnospiraceae, all of which were found to be present in 
metagenomic sequence analysis of total stool DNA (Fig. S2). Overall, 19 of the 
phage contigs sequenced here could be associated with bacterial hosts by at 
least one of the two approaches (Table S2), although for the great majority the 
hosts remain unknown. 
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2.4.6 Longitudinal Sequence Variation Driven by Diversity-Generating 
Retroelements 
Another force diversifying bacteriophage genomes are diversity-
generating retroelements (DGRs), which are reverse transcriptase-based 
systems that introduce mutations at adenines in specific repeated sequences 
using a copy–paste targeting mechanism (6, 30–33). We analyzed the viral 
contigs described here to investigate whether DGRs were detectably active 
within the human gut. DGRs were identified by searching contigs for regions that 
matched three criteria: (i) they contained proteincoding regions resembling 
reverse transcriptases, (ii) they encompassed short repeat regions containing 
mismatches in adenine positions, and (iii) they contained hypervariable regions. 
Of the 20 contigs with both a reverse transcriptase and an adenine mismatched 
repeat, six were associated with hypervariable regions (located no more than 100 
bp away; Table S3) and were selected for further study. As was found previously, 
hypervariation was directed toward asparagine AAY codons in genes encoding 
either predicted C-type lectin or Ig-superfamily proteins (6, 30–33). We next 
asked whether any of the DGRs were detectably active over the time series 
studied. The longest gap between sample collections was 22 mo, so to maximize 
sensitivity we asked whether the hypervariable regions had evolved to become 
clearly different over this time interval. Of the two hypervariable regions with 
sufficient longitudinal coverage for analysis, one (contig 42) showed change over 
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the 22-mo time period, and change was greater than for samples closer together 
in time (P < 0.0001) or for pairs of samples from the same time point (P < 
0.0001). For the second (contig d03-2), we did not obtain evidence for 
longitudinal variation. We conclude that one of our DGRs was active in the 
human gut. For the others, it is unclear whether they were inactive or whether we 
did not have enough sequence coverage to detect activity. Analysis showed that 
DGR containing contigs were not among the most variable, highlighting the local 
nature of DGR variation and emphasizing the contributions of other mechanisms. 
The possibility that some of the DGRs were inactive raises the question of 
whether the mutagenic activity might be regulated in the human host. 
2.5 Discussion  
Here we report a study of longitudinal variation in the human gut virome 
and some of the mechanisms responsible for change over time. Loss and 
acquisition of viral types was uncommon: Fully ∼80% of viral forms persisted over 
the 2.5-y time course studied, as is consistent with previous studies of shorter 
duration (4–6). Most viral contigs showed diversity within each time point and 
accumulated variation over time. Temperate DNA phages showed relatively 
modest rates of variation compared with lytic phage, as is consistent with 
temperate phage DNA replication by accurate bacterial polymerases in the 
prophage state, and potentially fewer total rounds of replication. In contrast, the 
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strictly lytic ssDNA Microviridae showed up to 4% substitutions in the major 
variants present over the time period studied. DGRs showed high diversity in 
variable repeat regions, and one was detectably active over the time series 
studied. CRISPR arrays encoded in viral genomes also were associated with 
longitudinal variation. Thus, multiple mechanisms contributed to viral sequence 
variation, and our data provide a detailed picture of their relative contributions. 
This study did not yield any clear examples of known DNA viruses infecting 
animal cells. Rare reads did align to genomes of animal cell viruses, but it is 
uncertain whether these alignments represent true detection of these viruses or 
rare regions of homology between animal cell viruses and phages. In contrast, 
several studies have reported frequent detection of animal cell viruses in 
metagenomic analysis of stool DNA from humans and other primates, raising the 
question of how these studies differed. One observation is that samples from sick 
individuals (34, 35) or SIV-infected macaques (36) have yielded animal cell 
viruses more frequently than samples from healthy controls. Some of these 
studies did not attempt to analyze bacterial viruses, instead using bioinformatic 
filters to extract animal cell viruses from complex sequence mixtures, potentially 
leading to an under-appreciation of the size of the phage populations. Thus, our 
data emphasize that in the healthy human gut bacterial viruses are much more 
numerous than animal cell viruses, although it remains possible that some of our 
contigs with no database matches correspond to previously unknown viruses 
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infecting human cells. Given the findings reported here, we can return to the 
question of why human gut viromes differ so greatly among human individuals. 
One factor must be the differences in bacterial populations in the guts of different 
humans. Many metagenomic studies emphasize that, although the human gut 
typically contains bacteria from only a few phyla, the bacterial strains are mostly 
different between individuals (11–13). Phages can be highly selective for different 
bacterial lineages—indeed, phage sensitivity is used clinically to distinguish 
some bacterial strains (e.g., refs. 37 and 38)—likely explaining some of the 
differences in phage populations in different individuals. However, a second 
basis for the differences among individuals, highlighted in data reported here, is 
rapid within-host viral evolution. Microviridae lineages showed up to 4% 
substitution in the main variant over the 2.5-y period studied, consistent with 
laboratory experiments also showing high mutation rates for Microviridae (39). 
There is no single threshold of sequence identity accepted for splitting related 
viruses into separate species (40), but different Microviridae species specified by 
the International Committee on Taxonomy of Viruses show as little as 3.1% 
divergence (Table S4). Evidently the divergence seen here for Microviridae 
contigs 122_321 and 001_39 approaches the level sufficient for designation as 
speciation events. Extrapolating from these rates, our data suggest that multiple 
new viral species commonly will arise in the gut of a typical human over the 
course of a human life. Thus, part of the explanation for the extremely large 
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populations of gut viruses inferred from sequence information and for the 
extreme differences among individual humans appears to be rapid within-
individual evolution of long-term viral residents. 
2.6 Methods 
  Longitudinal stool samples were collected from a single healthy male adult 
under a protocol approved by the Internal Review Board of the Perelman School 
of Medicine at the University of Pennsylvania. Samples of viral particles were 
purified by filtration, Centricon ultrafiltration, and nuclease treatment, and then 
total DNA was extracted using the QIAamp DNA Stool kit. Sequence information 
was acquired using Illumina paired-end technology. Sequences were assembled 
by iterative deBruijn graph assembly using MetaIDBA, and contigs were 
combined using Minimo. Taxonomy was assigned using Blastp, ORFs were 
predicted using Glimmer, and bacterial taxa were called using Metaphlan. 
Oligonucleotides used in this study are presented in Table S5. All sequence 
information has been deposited at the National Center for Biotechnology 
Information. For further details see SI Methods. 
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2.7 Figures 
Figure 1 
 
Fig. 1. Longitudinal analysis of the human gut virome from a single individual. (A) Timeline of 
sample collection. Note that at some time points, two separate portions of the stool sample, taken 
approximately 1 cm apart, were processed and sequenced independently to assess 
reproducibility. (B) Rarefaction analysis of sampling depth by number of reads; detection of each 
contig is scored as positive if 50% of the contig is covered by sequence reads. (Inset) Contig 
recovery. The x-axis is the number of samples included (black line: 2 million reads; blue line: 15 
million reads). (C) Contig spectrum, relating the lengths of the contigs assembled in bas pairs (x-
axis) to the depth of coverage (y-axis). Circular contigs are shown as blue and linear contigs as 
red. 
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Figure 2 
 
 
 
 
 
 
 
 
 
Fig. 2. Stability and change in the gut virome of the individual studied. (A) Conserved 
membership in the viral community over time intervals analyzed using the Jaccard index. 
Because many pairwise comparisons are possible between the 24 time points, we plotted shared 
membership for all pairs of time points as a function of the length of time between each pair. The 
x-axis shows the time interval between time points, and the y-axis shows shared membership in 
the two communities compared summarized using the Jaccard index. Perfect identity yields a 
value of 1, and complete divergence yields a value of 0. (B) Comparison of substitution rates 
among viral families. Temperate phages are shown in blue, and lytic phages are in red. The viral 
families studied are shown at the bottom; substitution rates on the y-axis are substitutions per 
base, per day. Only contigs with clear taxonomic attributions were analyzed; such contigs 
comprise a minority of all contigs. 
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Figure 3 
 
Fig. 3. Longitudinal DNA substitution in Microviridae. (A) Substitution rates in the four Microviridae 
genomes with the highest values measured. Because many pairwise comparisons are possible 
between the time points at which each virus was detected, the plot shows distances between time 
points on the x-axis and the percent substitution on the y-axis. The percent substitution values 
within each time point were subtracted from the between-time point values before the plot was 
constructed. Colors differentiate the four viruses studied. (Inset) The genome with the highest 
substitution rate (contig 122_321). (B) Phylogenetic tree of microphages detected in this and 
other studies. The four microphage contigs with the highest substitution rates observed in this 
study are shown in large black lettering. Database microphages are shown in red, microphages 
from ref. 6 are shown in green, and additional microphages identified in this study are shown in 
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blue. (Scale bar: the proportion of amino acid substitutions within the 919-aa major coat protein, 
which was aligned to make the tree.) Longitudinal maps of substitution accumulation are shown 
to the right. Note that all of the variations shown in the sequences to the right are plotted in the 
phylogenetic tree but are not visible because of the comparatively low divergence. Only time 
points with high-quality complete-genome assemblies are shown. 
 
Figure 4 
 
Fig. 4. Relative abundance of SNPs in four Microviridae genomes analyzed longitudinally. 
Contigs studied are marked above each figure panel. The x-axis shows elapsed time since the 
start of the study. The y-axis shows the relative proportion of each variant in the population. The 
dashes on the x-axis show replicate analysis of single time points, allowing assessment of within-
time point variability. Only positions with SNPs that transitioned from minor (0.5) are plotted. The 
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colors are used to make the different positions easier to visualize. Panel labels A–D show data for 
the contigs indicated at the top of each panel. 
 
Figure 5 
 
Fig. 5. A phage-encoded CRISPR array targeting another phage. The array shown (contig 117) 
was detected in the viral contig collection. Gray indicates CRISPR repeats, and colors indicate 
CRISPR spacers. The target contig (contig 102) also was identified and observed to be present at 
some of the same time points; three other contigs also were targeted by the CRISPR array in 
contig 117. The CRISPR array in viral contig 117 is closely similar to CRISPR-2 detected in the 
total stool metagenomic sequencing. 
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Figure S1 
 
Fig. S1. Reproducibility between replicates. Each point represents the normalized abundance of a 
contig in a pair of replicate virome samples from the same time point. All contigs and pairs of 
technical replicates are represented in the figure. 
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Figure S2 
 
Fig. S2. Bacterial species detected in Illumina sequencing of unfractionated stool DNA. Bacterial 
lineages were identified using MetaPhlan. 
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Figure S3 
 
Fig. S3. A possible case of an escape mutation allowing evasion of CRISPR pressure. An 
example of bacterial CRISPRs targeting viral contig 111_52 and a possible example of an escape 
mutation. (A) Mapping of bacterial CRISPR target sites on the phage genome. The CRISPR 
spacer targets are shown by the arrows, and the spacer described in B is indicated by the 
asterisk. (B) Longitudinal abundance of a phage genome with an additional mismatch at a 
CRISPR homologous site. The genome containing an additional mismatch in the CRISPR 
recognition site (red) versus the original sequence (blue) increased in abundance over time. 
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3.1 Abstract 
The genomic DNAs of tailed bacteriophages are commonly modified by 
attachment of chemical groups.  Some forms of DNA modification are known to 
protect phage DNA from cleavage by restriction enzymes, but others are of 
unknown function.  Recently the CRISPR-Cas nuclease complexes were shown 
to mediate bacterial adaptive immunity using RNA-guided target recognition, 
raising the question of whether phage DNA modifications may also block attack 
by CRISPR-Cas9.  We investigated phage T4 as a model system, where 
cytosine is substituted with glucosyl-hydroxymethylcytosine (glc-HMC).   We first 
quantified the extent and distribution of covalent modifications in T4 DNA using 
single molecule DNA sequencing and enzymatic probing. We then designed 
CRISPR spacer sequences targeting T4, and found that wild-type T4 containing 
51 
 
glc-HMC was insensitive to attack by CRISPR-Cas9, but mutants with 
unmodified cytosine were sensitive.  Phage with HMC only showed intermediate 
sensitivity.  While this work was in progress, another group reported examples of 
heavily engineered CRISRP-Cas9 complexes that could in fact overcome the 
effects of T4 DNA modification, indicating that modifications can inhibit but do not 
always fully block attack. 
3.2 Importance 
Bacteria were recently found to have a form of adaptive immunity, the CRISPR-
Cas systems, which use nucleic acid paring to recognize and cleave genomic 
DNA of invaders such as bacteriophage.  Historic work of tailed phages has 
shown that phage DNA is often modified by covalent attachment of large 
chemical groups.  Here we demonstrate that DNA modification in phage T4 
inhibits attack by the CRISPR-Cas9 System.  This finding provides insight into 
mechanisms of host-virus competition, and also a new set of tools that may be 
useful in modulating the activity of CRISPR-Cas9 in genome engineering 
applications. 
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3.3 Introduction 
The functional importance of covalent DNA modification was first 
demonstrated in 1952 in studies of bacteriophage (1, 2).  In bacteriophage T4, 
genomic DNA contains 5-hydroxymethylcytosine (HMC), which is further 
modified by attachment of glucose to yield glucosyl HMC (glc-HMC) (Fig. 1) (3-
6).  Incorporation of HMC blocks DNA cleavage by many restriction 
endonucleases, and the glc-HMC modification further blocks attack by the HMC-
specific McrABC (Rgl/MspJI) nuclease. Today more than ten different types of 
covalent modification are known in bacteriophage DNA, many of which are of 
unknown function (7, 8).  Eukaryotic DNA also can be modified to methyl-
cytosine, hydroxymethyl-cytosine and glucosylated 
hydroxymethyldeoxyuridine(9, 10). 
Recently striking studies have revealed a new class of nucleases in 
bacteria, the CRISPR-Cas systems, which provide bacteria with a form of 
adaptive immunity against infection by genomic parasites such as phages or 
plasmids(11-17).  Short sequences from genomic parasites are incorporated into 
CRISPR arrays in the bacterial chromosome, which consist of repeated 
sequences and unique spacers (typically ~30 nt) that are derived from 
invaders(18-20).  Transcription of the arrays and RNA processing produces 
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spacer RNA sequences (crRNAs), which are bound by a nuclease (Cas9 for the 
type II CRISPR systems)(21).  The crRNA is then used to recognize DNA of 
invaders by base pairing, allowing subsequent nucleic acid cleavage by Cas9(22) 
(reviewed in (23-25)).  These programmable nuclease systems are now used 
widely in biotechnology applications (26-31). 
The discovery of the CRISPR-Cas9 system raised the question of whether 
T4 DNA modification might have an additional function—protecting phage DNA 
from cleavage by CRISPR-Cas9.  One previous paper analyzed the effects of a 
smaller DNA modification--adenine N6 methylation--and showed that phage DNA 
with this modification was still sensitive (32).  Another study demonstrated that 
genome engineering by Cas9 in eukaryotes is also unaffected by 5-methyl 
cytosine (33).    Here we investigate the effects of the larger DNA modifications 
found in T4.  We first characterize T4 DNA modification in detail using single 
molecule sequencing and nuclease digestion.  We go on to show that the bulkier 
HMC and glc-HMC modifications can in fact inhibit CRISPR-Cas9 attack. While 
this work was in progress, another group reported examples were T4 with glc-
HMC modification could be in fact be sensitive to attack by CRISPR-Cas9, which 
we further analyzed and attribute to use of a heavily engineered and optimized 
CRISPR-Cas9 system (34). 
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3.4 Results 
3.4.1 The extent of modification in T4 and mutant derivatives 
Prior to testing sensitivity to CRISPR-Cas9, wild-type bacteriophage T4 
(termed “T4(glc-HMC)” in the following) and mutants altered in DNA modification 
were analyzed to characterize the nature and extent of genomic DNA 
modification.  T4(147) is mutant in genes encoding the alpha and beta glucosyl 
transferases, which attach glucose to HMC DNA, so that genomes contain HMC 
only (termed “T4(HMC)” in the following).  T4(GT7) is mutant in genes required to 
substitute HMC for dCTP in nucleotide pools, so genomes contain only 
unmodified cytosines (termed “T4(C)” below).  Complete T4 genotypes are in 
Table S1.   
Several studies were carried out to verify the presence of the expected 
DNA modifications in each phage and evaluate the extent of base substitution.  
First, genomic DNAs were purified from phage stocks and probed by exposure to 
DNA modifying enzymes of known specificities.  DNA from T4(C), but not 
T4(HMC) or T4(glc-HMC), was sensitive to digestion by the restriction enzyme 
AluI (Fig. 2A, top), as expected for DNA containing unmodified cytosines.  T4 
genomic DNAs were next incubated with MspJI, which cleaves HMC-containing 
DNA selectively.  T4(HMC) DNA was digested, but not T4(glc-HMC) or 
T4(C)(Fig. 2A, middle).  The T4 DNAs were also exposed to a glucosyl-
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transferase and a glucose donor, which resulted in reduced mobility of T4(HMC) 
DNA, consistent with glucose attachment to HMC, but no changes were 
observed for the faster migrating T4(C) or slower migrating T4(glc-HMC) (Fig. 
2A, bottom).  T4 DNA modification was further probed by infection of E. coli 
strains expressing the Rgl nuclease, which cleaves HMC-containing DNA 
selectively.  Infection by T4(HMC) was undetectable in Rgl-containing strains, but 
infection by T4(glc-HMC) or T4(C) was not restricted.  These data confirm the 
expected modification patterns in the T4 DNA stocks studied, and indicate that 
the extents of HMC incorporation and subsequent glucosyl conjugation are high, 
consistent with an analysis of nucleotides generated after enzymatic degradation 
of T4(glc-HMC) DNA (35). 
3.4.2 Single molecule sequencing to characterize T4 DNA modification 
To characterize the extent and distributions of DNA modifications in more 
detail, we subjected each T4 DNA sample to analysis by single molecule real-
time (SMRT) sequencing using Pacific Biosciences technology (36, 37).  In this 
method, single DNA molecules are sequenced by synthesis on immobilized DNA 
polymerase enzymes.  Sequence information is acquired by detection of 
fluorescently labeled nucleotides during each incorporation step.  The presence 
of DNA modifications in the template can slow the kinetics of incorporation, 
allowing DNA modification to be quantified as an increase in interpulse duration 
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(IPD).  IPD values are calculated for each position in the template sequence and 
are compared to an in silico model of IPD values for an unmodified sequence 
(IPD ratio) (38).  In favorable cases, different forms of DNA modification show 
distinguishable kinetic profiles (38-41). 
Figure 2B and Fig. S1A and B  summarize the SMRT sequencing results 
for T4(glc-HMC), T4(HMC), T4(C), and a T4 genome lacking all forms of 
modification made by copying wild-type T4 DNA with a DNA polymerase in vitro 
(whole genome amplification, “WGA”). Kinetic profiles of T4(glc-HMC) showed 
many increased IPD ratios associated with expected positions of glc-HMC (Fig. 
2B, top).  Particularly increased IPDs were seen for potential glc-HMC sites 3’ of 
a G residue, or 5’ of a pyrimidine (Fig. S2).  The mechanism of these sequence 
context effects is unknown--they could either reflect different extents of glucose 
attachment dependent on local sequence, or differential effects of sequence on 
polymerase kinetics.  Kinetic perturbations were also seen at additional base 
positions, commonly those near C residues in the sequence, suggesting that 
modifications may contact polymerase from nearby positions in the DNA chain.  
For T4(HMC), kinetic lags were also associated with sites of potential C 
modification (Fig. 2B, middle), but the magnitude of the effects were typically less 
than for T4(glc-HMC). For T4(HMC) modification, IPD ratios were particularly 
high for pairs of expected HMC residues (Fig. S2). T4(C) and the WGA DNA 
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showed no notable alterations in kinetics at C residues (Fig. 2B, bottom two 
panels).   
T4 also encodes an (N6-adenine)-methyltransferase that methylates A 
residues at 5’-GATC-3’ sequences.  The role of this modification is unknown, but 
it may help protect T4 DNA from the cellular methyl-directed mismatch repair 
system, which carries out double strand cleavage when mismatches are detected 
near unmodified 5’-GATC-3’ sequences (42-44).  Methylation was evident as 
increased IPD values at A in 5’-GATC-3’ in all three T4 genomic DNAs but not in 
the WGA control. However, the extents of modification differed (Fig. 2C).  The 
extent of 5’-GATC-3’ adenine methylation was higher in both T4(C) and T4(HMC) 
than in T4(glc-HMC) DNA, paralleling a previous report (45).  This is consistent 
with a steric interference model, which posits that glucosylation of HMC obstructs 
access of the adenine methyltransferase to T4 DNA and thereby reduces the 
extent of 5’-GATC-3’ adenine methylation.  
Sequencing data for T4(C) showed a high proportion of reads that 
mapped to the E. coli genome (56.7%; Fig. S3).  Far fewer E. coli reads were 
detected in the T4(glc-HMC) and T4(HMC) samples (1.5% and 0.8% 
respectively).  The T4(C) strain has been widely used in generalized transduction 
for genetic mapping in E. coli (46-48).  T4(C) contains a mutation that inactivates 
the gene encoding the denB nuclease, which normally degrades host cell DNA, 
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thus allowing E. coli DNA to compete for packaging in T4 particles, as well as 
mutations inactivating the T4 encoded dCTPase and dCMP hydroxymethylase 
enzymes.  In T4(C), different segments of the E. coli DNA was not packaged with 
uniform frequency (Fig. S3), suggesting possible involvement of sequence-
specific recognition during T4 packaging(49).  
3.4.3 Inhibition of CRISPR-Cas9 by T4 DNA modification 
Given that the densities of DNA modification in T4(glc-HMC) and T4(HMC) 
are high, we sought to investigate whether the CRISPR-Cas system was blocked 
by T4 DNA modification.  As a representative CRISPR-Cas system, we chose 
the type II system of Streptococcus pyogenes, because it has been widely used 
in biotechnology applications and functions well in E. coli (27).  CRISPR spacers 
(targeting sequences) were designed to target four regions of the T4 genome 
(termed “protospacers”), each proximal to the required downstream 5’-NGG-3’ 
protospacer adjacent motif (PAM) in the T4 target.   
Protospacer sequences and T4 DNA modification densities in these 
regions are shown in Fig. 3.  The spacers were designed to target regions of the 
T4 genome with varying cytosine arrangement and density.  None of the spacers 
contain the adenine methylation target sequence, GATC. Spacer T4 CRISPR 1 
was designed to target a region of the T4 genome that maximizes the number of 
cytosines on the target strand and in the “seed sequence”, which is the inferred 
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3’ region of the CRISPR RNA that is reported to be most important for 
recognition (50). Spacer T4 CRISPR 2 maximizes the number of cytosines or 
modified derivatives on both the target and complementary strands in the T4 
protospacer.  Spacer T4 CRISPR 3 minimizes the number of cytosines in the 
target strand, but maximizes the number of cytosines on the complementary 
strand of the T4 protospacer.  Spacer T4 CRISPR 4 minimized the numbers of 
cytosine residues on both the target and complementary strands of the T4 
protospacer.  IPD ratio analysis of T4(glc-HMC) and T4(HMC) DNA showed 
slowed kinetics at C-residues in the complement of the 5’-NGG-3’ PAM 
sequence and at internal cytosines, indicative of DNA modification.   
The efficiency of phage infection was then tested on the CRISPR-Cas9-
containing strains. To confirm the CRISPR system was active using our 
engineered spacers, we transformed the CRISPR-Cas9 containing bacteria with 
pUC19-derived plasmids encoding either the corresponding T4 protospacers and 
PAM sequences or a nonspecific control sequence (Fig. 4A).  Using 
spectinomycin antibiotic selection for the target plasmid, we quantified efficiency 
of transformation, comparing the number of bacteria containing the incoming 
plasmid with a target matching T4 protospacer versus a control plasmid lacking 
the target (Fig. 4B).  All of the CRISPR-Cas9 containing bacteria showed 
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reduced acquisition of the target-containing plasmid, indicating that the CRISPR 
systems are functional and reduce transformation by at least two logs (Fig. 4B).   
The ability of T4 and mutant derivatives to infect CRISPR-Cas9 containing 
bacteria was then scored in plaque assays (Fig. 4C).  Figure 4D-F shows 
illustrative experiments in which T4 phage were plated on CRISPR-Cas9-
containing strains or controls and the efficiency of plaquing quantified. Infection 
with the cytosine-only strain T4(C) resulted in reduced or undetectable plaque 
formation in the presence of the T4-targeting spacers (Fig. 4D, right-most four 
spacers). Plaque formation was not affected by the presence of Cas9 and a 
nonspecific spacer, or in E. coli with no CRISPR-Cas9 system (Fig. 4D, left two 
samples marked “None” and “non-sp”).  T4 CRISPR 1 showed the weakest 
activity, possibly due to high G/C content or the presence of homopolymeric 
sequences in the crRNA, which were previously reported to inhibit function (51).  
Titration studies on strains containing Cas9 and CRISPR 2, 3, and 4 showed the 
efficiency of plating to be reduced by >10,000-fold. CRISPR1 was weaker, 
showing only about 3-fold reduction, paralleling many studies showing variation 
in the efficiency of CRISPR targeting. 
T4(glc-HMC), in contrast, formed plaques on strains expressing T4 
CRISPR 1-4 and Cas9 efficiently (Fig. 4E).  Infection of three of the four 
CRISPR-containing strains was as efficient as for the strains with control 
61 
 
nonspecific spacers.  The fourth (T4 CRISPR 4) contained the spacer with the 
fewest modified C resides on both DNA strands, and so the lowest modification 
density.  Infection by T4(glc-HMC) was reduced 2-10 fold in repeated assays, 
and plaque size was reduced by about two-thirds, indicating some sensitivity.  
Note that two modified cytosines are present in T4 CRISPR 4 target in the DNA 
complementary to the 5’NGG’3 PAM, and glucosylation of these likely exerted 
some inhibition.  A previous study showed both DNA strands of the PAM are 
important for target recognition in other CRISPR systems(52).   T4(glc-HMC) 
infection was not inhibited in strains expressing T4 CRISPR 3, which contains no 
cytosines on the target DNA strand but seven on the complementary strand, 
indicating that modifications on either strand can interfere with CRISPR attack.  
Thus glucosylation of HMC mostly protects T4 from attack by the CRISPR-Cas9 
system, but a region with few glc-HMC residues showed modest but detectable 
sensitivity. 
For T4(HMC)(Fig. 4F), the T4 CRISPR 1-3 targeting constructs did not 
inhibit infection, indicating that substitution of cytosine with HMC was also 
sufficient to block CRISPR-Cas9 attack.  However, for T4 CRISPR 4, which has 
the fewest C residues on both the target and complementary strands, T4(HMC) 
was highly sensitive—efficiency of plating was reduced by at least 10,000-fold 
(Fig 4F).  This indicates that the HMC modification alone on the cytosines on the 
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complementary strand of the 5’-NGG-3’ PAM is not enough to inhibit CRISPR-
Cas9 attack.  Evidently the HMC modification is a less effective blocker than the 
glc-HMC modification, though both suffice at a high enough density.  
3.4.4 Comparison to results of Yaung et al. 
 While this work was in progress, Yaung et al. reported three spacers in an 
engineered type II CRISPR system that were functional against wild-type T4(glc-
HMC) phage and a T4 mutant containing HMC DNA (34).  We obtained their 
spacer plasmids, and confirmed that they were able to restrict growth of 
T4(HMC) and T4(glc-HMC) phage in plaque assays as reported (Fig. S4A&B).  
These spacers differed from ours in that the crRNAs were engineered so that 
they were fused to tracrRNAs also know as a single-guide RNAs(26).  The 
tracrRNA is a small RNA bound by Cas9 that is required for crRNA processing 
and as a cofactor for Cas9 nuclease activity(53).  Fusion of the two RNAs is 
convenient in some genome engineering applications (26).   
We cloned the spacers of Yaung et al. into the type II CRISPR system 
used in our studies, where crRNAs are not fused to tracrRNA, as in the natural S. 
pyogenes CRISPR-Cas9 system.  We found that two of the three spacers were 
ineffective against the modified DNA of phage T4(glc-HMC) (Fig. S4D), but all 
three spacers were effective against unmodified DNA (Fig S5).  Two of the 
spacers restricted growth of T4(HMC), while the third showed partial activity (Fig. 
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S4C).  We confirmed that the Cas9 nucleases used here and by Yaung et al. 
functioned similarly in side-by-side tests, indicating that the CRISPR RNAs and 
not the Cas9 nuclease were responsible for the functional differences (Fig. 
S5E&F).  Evidently the spacers of Yaung et al., with the synthetic single-guide 
RNA fusion, shows higher activity against modified T4 DNA (Fig. S4).   These 
data indicate that DNA modifications can inhibit a biologically-occurring type II 
CRISPR system, but that particularly potent crRNAs can overcome this inhibition.  
With the model system available to study CRISPR-Cas9 attack on T4, we 
were able to address further questions of T4 biology as described below. 
3.4.5 Testing the role of T4 IP proteins 
Three T4 proteins are injected into E. coli along with T4 DNA early during 
infection (IPI-III) and bind the T4 genome (54).  IPI protects T4 from the 
GmrS/GmrD restriction enzyme, but the function of IPII and IPIII are unknown 
(55) —we thus asked whether any of the IP proteins contributed to evasion of the 
CRISPR-Cas9 system.  This study was motivated in part by a previous report in 
which Pseudomonas phages were shown to encode protein inhibitors of a 
CRISPR-Cas system (56).  For T4, such proteins would hypothetically be 
required for DNA modifications to exert their protective effect.  A T4(glc-HMC) 
strain mutant in all three IP genes was tested by infection of strains containing 
the T4 targeting CRISPRs.  No difference in infectivity was observed, indicating 
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that the IP proteins are not cofactors required to allow DNA modification to inhibit 
attack by CRISPR-Cas9 (Fig. S6).  However, we note that there are multiple 
types of CRISPR-Cas systems that are quite different from each other, and T4 
can infect Escherichia, Shigella and Yersinia (57), so it would be of interest to 
test possible inhibition of additional CRISPR-Cas systems from these organisms. 
 
3.4.6 Characterization of a revertant of T4(C) with reduced sensitivity to 
CRISPR-Cas9 
We observed a T4(C) revertant that reduced sensitivity to CRISPR-Cas9, 
and so characterized it further. Normally T4(C) plaques are small and turbid.  
During growth, we observed appearance of a new variant generating large clear 
plaques resembling T4(glc-HMC) plaques.  Further tests showed reduced 
sensitivity to CRISPR-Cas9 (FigS7 C data).  We sequenced the revertant phage, 
named T4(C)R and identified three mutations (FigS7 A and B). One point 
mutation eliminated the stop codon in gp42, which encodes dCMP 
hydroxymethylase, an enzyme necessary to synthesize HMC.  A second 
mutation introduced a single nucleotide deletion into the deoxycytidylate 
deaminase gene, yielding a stop codon that truncated the encoded protein.  
Deoxycytidylate deaminase converts dCMP (a precursor of HMC) to dUMP.  
Both of these mutations favor the synthesis of HMC, which can be incorporated 
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in the T4(C)R genome and then further modified to glc-HMC by alpha and beta 
glucosyl transferases.  The third mutation was a nonsynonymous point mutation 
in the uncharacterized, hypothetical protein NrdC.5, and is of unknown 
significance.  
T4(C)R was resistant to spacers 1,2, and 3 in the CRISPR-Cas9  system, 
but sensitive to spacer 4 (FigS7 C), thus showing slightly greater sensitivity than 
wild-type T4(glc-HMC). These results and other results are consistent with the 
idea that T4(C)R contains HMC or glc-HMC, though potentially not at every 
position in the genome due to higher cellular dCTP pools competing for 
incorporation. These findings again support the idea that DNA modifications can 
block CRISPR-Cas9 activity. 
 
3.5 Discussion 
 These data show that modification of T4 DNA to HMC or glc-HMC reduces 
sensitivity to attack by CRISPR-Cas9.  A previous study showed that adenine 
methylation at a 5’-GATC’3’ sequence did not block CRISPR-Cas-mediated 
inhibition (32), and data presented here shows that low density modification with 
HMC also was not protective.  Evidently protection against CRISPR-Cas9 attack 
can be achieved either by addition of bulkier glucosyl-HMC modifications or 
addition of a high density of less bulky HMC modifications.   
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While this work was in progress, and contrary to our developing data, 
Yaung et al. reported spacers that could in fact target glc-HMC modified T4 DNA 
efficiently (34).  Our own tests with the reagents of Yaung et al. confirmed their 
conclusions. The Cas9 enzymes used were identical in both studies, specifying 
the RNA component as the origin of the different potency.  Yaung et al. used 
crRNAs fused to tracrRNAs, which could have potentially improved activity by 
favoring RNA loading onto Cas9, or increased specific activity of the loaded 
sgRNA/Cas9 complex.  One of the crRNAs of Yaung was notably potent even 
without the tracrRNA fusion, suggesting that for this spacer fusion with the crRNA 
did not explain potency.  Another candidate explanation is that the positions of 
base modifications in the recognition site may be important, and that the rules for 
this are not fully clarified.  For all spacers studied here, we have not investigated 
whether cleavage mediating T4 inhibition is in fact due to on target or off target 
cleavage, so increased off target specificity is another possible explanation for 
increased inhibition (58).  
Classic studies on the tailed DNA phages have identified more than ten 
different forms of covalent DNA modification, and modification is commonly found 
in DNA of these viruses (7, 8).  Recent metagenomic studies also emphasize the 
ubiquity of CRISPR systems targeting phage in natural environments such as the 
human microbiome (59-61).  There are even examples of phage from the human 
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gut that themselves encoding CRISPR spacers targeting other phage from the 
same individual, indicating that phages may be competing with each other using 
the CRISPR-Cas system (60, 61).   Given these observations, and data shown 
here that modification of T4 DNA to HMC or glc-HMC can reduce sensitivity to 
attack by CRISPR-Cas9, it seems probable that many of the bulkier forms of 
DNA modification seen in tailed DNA phage have evolved at least in part to 
reduce sensitivity to cleavage by CRISPR-Cas systems.   
 
3.6 Materials and Methods 
Propagation of phage strains. Manipulation of phage T4 was carried out as 
described in (62).  Phage T4(glc-HMC), T4(HMC), and T4(C) were provided by 
Lindsay Black. Genotypes are listed in Table S1.  T4(C) contains amber 
mutations in several DNA modifying genes (Table S1).  The amber mutations are 
known to easily revert so T4(C) was propagated in the amber suppressor strain 
E.coli CR63 to prevent genotype reversion.  Experiments with T4(C) were carried 
out in the non-suppresser E.coli strain DH10B ensure cytosines in T4(C) were 
unmodified.   Experiments and propagation of T4(glc-HMC) and T4(HMC) were 
carried out in DH10B. Experiments with T4(IP0) were carried out in E.coli B834.  
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CRISPR system and spacer design.  Design of CRISPR spacers was carried 
out using custom code in R attached in Supplementary Material. CRISPR 
targeting plasmids were constructed using the system described by L. Marraffini 
and coworkers(27), which consists of two plasmids pCas9 and pCRISPR.  pCas9 
contains the Cas9 nuclease and tracrRNA (Addgene number 42876). Spacers in 
this study were cloned into the CRISPR array on pCRISPR (Addgene number 
42875) using the Marraffini lab protocol available on Addgene.  Comparison of 
work to Yaung et al.  was carried out using plasmids DS-SPCas (addgene 
number 48645), PM-SP!TB (addgene number 48650) and plasmids provided by 
Yaung et al.  Oligos used for cloning are listed in table S2. 
 
Plasmid transformation assays. T4 protospacer and PAM sequences used in 
this study were individually cloned into pUC19 plasmids.  100ng of 
protospacer/PAM containing pUC19 were transformed into chemically competent 
E. coli DH10B containing a CRISPR-Cas9 system targeting the corresponding 
protospacer. As a transformation control, 100ng of pUC19 without a protospacer 
was transformed into DH10B containing a CRISPR-Cas9 expression system.  
Transformations were incubated at 37oC for 1hr in 200uL SOC media without 
antibiotic selection then plated on LB 100ug/mL carbenicillin plates to select for 
pUC19.   Efficiency of transformation was determined by dividing the number of 
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colony forming units observed in the protospacer containg pUC19 transformation 
by the number of colony forming units observed in the control pUC19 
transformation. 
 
 Plaque assays. Plaque assays were used to determine the ability of phage to 
infect bacteria DH10B containing the CRISPR-Cas9 system.  Up to 104 phage 
PFUs in a volume of 10uL were added to 200uL of log phase E.coli DH10B and 
incubated at room temperature for 10min.  3mL of 0.4% LB top agarose were 
added to the bacteria/phage, mixed, and poured onto LB plates containing 
appropriate antibiotics:100ug/mL kanamycin for pCRISPR, 50ug/mL 
chloramphenicol for pCas9,  100ug/mL ampicillin for DS-SPcas and 50ug/mL 
chloramphenicol for PM-SP!TB.  Plates were incubated at 37oC overnight.  Three 
biological replicates, each with three technical replicates, were carried out per 
experiment. The efficiency of plaquing was determined by dividing the number of 
plaques on an experimental plate by the number of plaques on a control plate 
containing E.coli with no CRISPR system.  A Kruskal-Wallis nonparametric 
comparison of means was carried out using GraphPad Prism software for each 
experiment. 
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Phage DNA isolation and sequencing.  Phage lysates were grown at an MOI 
of 0.01 on DH10B. Phage T4 DNAs were isolated using Norgen Phage DNA 
isolation kit (Thorold, Canada).  Chloroform-treated phage lysates were 
concentrated by 4% precipitation in PEG4000/500 mM NaCl, resuspended into 
TE buffer, and purified as recommended.   The concentration of isolated T4 
phage DNAs was measured using Quant-iT™ PicoGreen® dsDNA Assay Kit 
(Carlsbad, CA).  For single molecule sequencing, purified phage DNA was 
fragmented to an average size of 1.5 kb via adaptive focused acoustics (Covaris, 
Woburn, MA). SMRTbell template sequencing libraries were prepared as 
previously described (63). Sequencing was carried out on an RS II (Pacific 
Biosciences, Menlo Park, CA) using P4/C2 sequencing chemistry and standard 
protocols for large insert libraries.  Consensus sequences were generated using 
Quiver and kinetic data was generated with SMRT Analysis Software v2.0 
(Pacific Biosciences). For further methods see SI Methods. Libraries for 
sequencing T4(C) and T4(C)R were made using Illumina’s Nextera XT DNA 
Sample Preparation Kit with 1 ng of input DNA, generating paired-end fragments. 
Metagenomic sequencing was performed on an Illumina MiSeq instrument.  
Paired-end reads from the MiSeq instrument were quality-trimmed.  Reads were 
aligned using Geneious to the NCBI T4 genome sequence to form consensus 
sequences for T4(C) and T4(C)R. 
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Nuclease Assays. 1ug of T4(C), T4(HMC), and T4(glc-HMC) were digested with  
AluI (NEB: R0137s), MspJI (NEB: R0661S), and T4 phage β-glucosyltransferase 
(NEB: M0357S) using NEB specified protocols. 
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3.7 Figures 
Figure 1 
 
DNA modification in phage T4 showing C-containing DNA (left), HMC-containing DNA (middle), 
and glc-HMC DNA (right). 
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Figure 2 
 
FIG 2 Characterization of phage T4 DNA modification. (A) Phage T4(glc-HMC), T4(HMC), and 
T4(C) DNA left untreated () or treated with () restriction enzymes AluI (top), which cleaves 
unmodified DNA; MspJI (middle), which cleaves HMC-containing DNA; or T4 glucosyltransferase 
(bottom), which increases the mobility of HMC-containing DNA by the addition of glucose groups. 
The arrows indicate the mobility shift due to glucose attachment. (B) Analysis of phage T4 DNA 
modification by single-molecule sequencing. Results are summarized for each genome by 
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mapping IPD ratios at each base for each of the T4 strains studied. The coloration of each base 
is shown by the key at the bottom left. The T4 nucleotide sequence runs from top to bottom for 
each of the four genomes. The distance each colored point is displaced from the center indicates 
the IPD ratio (scale at bottom; leftward for the reverse strand, rightward for the forward strand). 
Examples of interpulse distances (indicative of modification) are shown to the right for a short 
segment of the T4 genome. Bars indicate the magnitude of the IPD ratio (upward for the forward 
strand and downward for the reverse strand).A 5=GATC 3=site of DAM methylation is highlighted 
in yellow. (C)Violin plot showing IPD ratios of A residues at 5= GATC 3= sequences.  
 
Figure 3 
 
FIG 3 IPD modification profiles of T4(glc-HMC), T4(HMC), and T4(C) phage protospacers. IPD 
ratios for the forward strand (blue) and reverse strand (red) of T4(glc-HMC), T4(HMC), and T4(C) 
are depicted for the regions of the T4 genome targeted by spacers 1 to 4 along with the 
surrounding nucleotides. The nucleotide sequences of the phage protospacer (orange), the PAM 
(green), and the surrounding nucleotides (black) are along the x axis. The top strand of the 
protospacer is identical in sequence to the crRNA/spacer, and the bottom strand is the target 
strand, which is complementary to the spacer and will base pair with the crRNA. 
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Figure 4 
 
FIG 4 Glc-HMC and HMC modifications inhibit attack by the CRISPR-Cas9 system on phage T4. 
(A) Diagram of the strategy used to validate CRISPR spacers in a transformation assay. Bacteria 
containing the type II CRISPR system were transformed with a pUC19 plasmid containing either 
a T4 protospacer and PAM sequence or a nonspecific DNA sequence. Antibiotic selection for the 
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pUC19 plasmid and quantification of the efficiency of transformation reveal the efficacy of 
CRISPR system cleavage of unmodified DNA containing a protospacer and PAM. (B) Results of 
plasmid challenge tests. The efficiency of transformation is the ratio of colony counts of cells 
transformed with equal amounts of pUC19 that contain a protospacer targeting the plasmid 
(numerator) to the colony counts of cells transformed with pUC19 (denominator). (C) Diagram of 
plaque assays to assess inhibition of T4 infection with CRISPR-Cas9. (D to F) Results of plaque 
assays in which the E. coli strains indicated were infected with up to 1x104 PFU of T4(C) (panel 
D), T4(glc-HMC) (panel E), or T4(HMC) (panel F). E. coli strains expressed Cas9 and crRNAs 
targeting T4 or controls. Starting from the left in each panel, None indicates no crRNA or Cas9, 
non-sp indicates nonspecific crRNA, 1 contained the maximum number of cytosines in the target 
strand and seed sequence, 2 contained the maximum number of cytosines in the target and 
complementary strands, 3 contained no cytosines in the target strand and seven cytosines in the 
complementary strand, and 4 contained the fewest cytosines in the target and complementary 
strands. Mean values were compared with the Kruskal-Wallis test. *, P < 0.01; ***, P < 0.0001; ns, 
not significant. 
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FIG S1 (A) Read lengths in the single-molecule sequence data sets. (B) Mapped subread lengths 
in the single-molecule sequence data sets.  
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Figure S2 
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FIG S2 Heat map summarizing the effects of local sequences on IPD ratios at C residues. The 
base preceding the C residue in the sequence is marked 5′-base, and that following the C residue 
is marked 3′-base. The scale at the bottom summarizes the IPD ratios. 
 
 
 
 
 
 
79 
 
Figure S3 
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FIG S3 Sequence coverage maps for T4 strains comparing T4 (top) to E. coli B834 (bottom). 
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Figure S4 
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FIG S4 Comparison of our work with that of Yaung et al. (A and B) Results of plaque assays in 
which theE. coli strains indicated containing previously studied CRISPR spacers (C1 to C3) in the 
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Yaung-Church CRISPR system (in C) were infected with up to 100 PFU of T4(HMC) (panel A) or 
T4(glc-HMC) (panel B). CRISPR spacer labeling: None, no crRNA or Cas9; non-sp, nonspecific 
crRNA. E.O.P., efficiency of plating. (C and D) Results of plaque assays in which 
the E. coli strains indicated containing previously studied CRISPR spacers (C1 to C3) in the 
Marraffini CRISPR system (in M) were infected with up to 100 PFU of T4(HMC) (panel C) or 
T4(glc-HMC) (panel D). CRISPR spacer labeling: None, no crRNA or Cas9; non-sp, nonspecific 
crRNA. (E and F) Plaque assay results of the Church laboratory Cas9 expression vector with the 
Marraffiini CRISPR array on the T4 CRISPR spacers studied here. The Church Cas9 expression 
vector and the Marraffini CRISPR array containing the spacers studied in this investigation 
(spacers 1 to 4) and the previously studied spacers (C1 to C3) were tested for efficacy against 
T4(HMC) (panel E) and T4(glc-HMC) (panel F). Mean efficiency of transformation was compared 
to that of a nonspecific control with a t test. **, P < 0.001; ***, P < 0.0001; ns, not significant. 
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FIG S5 Results of plasmid transformation assay comparing the efficacies of all of the CRISPR 
spacers studied in this investigation against unmodified DNA. Efficiency of transformation was 
normalized to 1 by the transformation of a plasmid not targeted by the CRISPR system (control). 
Spacers 1 to 4 are from this study. C1 to C3 are the spacers from Yaung et al. cloned into the 
CRISPR-Cas9 system developed by the Church lab (in C) or the Marraffini lab (in M). Mean 
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efficiency of transformation was compared to the nonspecific control with a t test. ***, P < 0.0001. 
E.O.P., efficiency of plating.  
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FIG S6 Mutation of IP1-3 genes encoding the three T4 proteins that are injected along with the 
phage DNA does not reduce resistance to attack by CRISPR-Cas9. Shown are replicate 
infections with wild-type T4(glc-HMC) (A) and the triple mutant T4(IP0) (B), which show no 
differences in infectivity for the strains tested. Plaque assay with approximately 100 PFU of 
T4(glc-HMC) or T4(IP0) infecting E. colinot expressing CRISPR-Cas9 (None) 
or E. coli expressing CRISPR-Cas9 with spacers targeting a protospacer in the T4 genome with 
the maximum number of cytosines in the target sequence and seed sequence (1), the maximum 
number of cytosines in the target and complementary strands (2), the fewest cytosines in the 
target strand (3), the fewest cytosines in the target and complementary strands (4), or a 
nonspecific spacer that does not target the T4 genome (non-sp). The mean efficiency of plating 
(E.O.P.) for infection of cells with each spacer was compared to that of no-CRISPR-Cas9 control 
with a t test. No statistically significant differences were found. 
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Figure S7 
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FIG S6 Phenotype of a revertant of T4(C) named T4(C)R with reduced CRISPR sensitivity. (A) 
Genetic map of T4(C) and the revertant obtained by Illumina deep sequencing. The bottom black 
line represents the T4(glc-HMC) genome length, and black arrows indicate genes and the 
direction of transcription. Variations in the T4(C) genome compared to T4(glc-HMC) are blue for 
single nucleotide deletions, red for large deletions, and pink for nonsynonymous substitutions; red 
×’s represent early stop codons. The top black line represents the T4(C)R genome. Variations in 
T4(C)R compared to T4(C) are green for nonsynonymous mutations and blue for deletions. The 
green circle indicates reversion of a stop codon, and the green × indicates a stop codon. (B) 
Glycosylated hydroxymethylcytosine synthesis pathway in T4(glc-HMC) phage and mutations in 
T4(C) and T4(C)R. Proteins mutated in T4(C) are shown by red ×’s. T4(C)R acquired a mutation 
designated by a green × and reverted a previous amber mutation denoted by a green circle. (C) 
Reduced sensitivity to CRISPR attack in the revertant. The mean efficiency of plating (E.O.P.) for 
infection of cells with each spacer was compared with that of the no-CRISPR-Cas9 control with 
a t test. ***, P < 0.0001; ns, not significant.  
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3.8 Tables 
Table S1 
Table S1 Genotypes of bacteria and bacteriophages used in this study 
Phage 
(Nomenclature 
used in this 
paper) 
Alternative/
historical 
name 
Genotype 
T4(Glc-HMC) T4 wild type 
T4(HMC) T4147 gt1, gt7 
T4(C) T4GT7 amC87g42, amE51g56, rNB5060, alc
IPI (HA35) IP2 (amber HA100) IP3 (amber HA9)
 
IP0 IP0   
   
   
Bacteria  Genotype 
DH10B  F– mcrA (mrr-hsdRMS-mcrBC)  
CR63   -, serU60(AS), lamB63 
 
 
B834 hsdRB, hsdMb, Sup0, rgl+ 
K803  rk-, mk-, rgl-, supE44  
Table S2 
Oligo Name Oligo DNA sequence 5'-3' Function Source
T4_Top_70718_70747 AAACAAAAGTTTTAGGGAATTCTAGGGCGGAGAGG top oligo for cloning T4 spacer 1 into pCRISPR this study
T4_Bottom_70718_70747 AAAACCTCTCCGCCCTAGAATTCCCTAAAACTTTT bottom oligo for cloning T4 spacer 1 into pCRISPR this study
T4_ModA_Top_13205_13234 AAACGCCCAGGGAGCCCAAGGCGGAGGGTCAAGAG top oligo for cloning T4 spacer 2 into pCRISPR this study
T4_ModA_Bottom_13205_13234 AAAACTCTTGACCCTCCGCCTTGGGCTCCCTGGGC bottom oligo for cloning T4 spacer 2 into pCRISPR this study
T4_30.2_top_127687_127716 AAACTTCACTATCAAAACTTTCTTTATTTTCCTTG top oligo for cloning T4 spacer 3 into pCRISPR this study
T4_30.2_bottom_127687_127716 AAAACAAGGAAAATAAAGAAAGTTTTGATAGTGAA bottom oligo for cloning T4 spacer 3 into pCRISPR this study
T4_Top_116439_116468 AAACTTTATTTATCATATTTATAAATAGAATAAAG top oligo for cloning T4 spacer 4  into pCRISPR this study
T4_Bottom_116439_116468 AAAACTTTATTCTATTTATAAATATGATAAATAAA bottom oligo for cloning T4 spacer 4 into pCRISPR this study
Church1_top_pPCRISPR AAACATATCGAAAGCAATCAGGTTG top oligo for cloning T4 spacer C1  into pCRISPR adapted from Yaung et al. 2014 
Church1_bottom_pCRISPR AAAACAACCTGATTGCTTTCGATAT bottom oligo for cloning T4 spacer C1 into pCRISPR adapted from Yaung et al. 2014 
Church2_top_pPCRISPR AAACAAGAACTTCCAACCGGTAATG top oligo for cloning T4 spacer C2  into pCRISPR adapted from Yaung et al. 2014
Church2_bottom_pCRISPR AAAACATTACCGGTTGGAAGTTCTT bottom oligo for cloning T4 spacer C2 into pCRISPR adapted from Yaung et al. 2014
Church3_top_pPCRISPR AAACGATGCTGATGCTGAACTGTCG top oligo for cloning T4 spacer C3  into pCRISPR adapted from Yaung et al. 2014
Church3_bottom_pCRISPR AAAACGACAGTTCAGCATCAGCATC bottom oligo for cloning T4 spacer C3 into pCRISPR adapted from Yaung et al. 2014
70_puc19_top AATTCAAAAGTTTTAGGGAATTCTAGGGCGGAGAGGGGA top oligo for cloning T4 protospacer 1 into puc19 this study
70_puc19_bottom AGCTTCCCCTCTCCGCCCTAGAATTCCCTAAAACTTTTG bottom oligo for cloning T4 protospacer 1 into puc19 this study
ModA_puc19_top AATTCGCCCAGGGAGCCCAAGGCGGAGGGTCAAGATGGA top oligo for cloning T4 protospacer 2 into puc19 this study
ModA_puc19_bottom AGCTTCCATCTTGACCCTCCGCCTTGGGCTCCCTGGGCG bottom oligo for cloning T4 protospacer 2 into puc19 this study
30.2_puc19_top AATTCTTCACTATCAAAACTTTCTTTATTTTCCTTTGGA top oligo for cloning T4 protospacer 3 into puc19 this study
30.2_puc19_bottom AGCTTCCAAAGGAAAATAAAGAAAGTTTTGATAGTGAAG bottom oligo for cloning T4 protospacer 3 into puc19 this study
11_puc19_top AATTCTTTATTTATCATATTTATAAATAGAATAAAAGGA top oligo for cloning T4 protospacer 4 into puc19 this study
11_puc19_bottom AGCTTCCTTTTATTCTATTTATAAATATGATAAATAAAG bottom oligo for cloning T4 protospacer 4 into puc19 this study
30_Chruch1_top_puc19 AATTCAACACCACAAATATCGAAAGCAATCAGGTTAGGA top oligo for cloning T4 protospacer C1 into puc19 adapted from Yaung et al. 2014 
30_Church1_bottom_puc19 AGCTTCCTAACCTGATTGCTTTCGATATTTGTGGTGTTG bottom oligo for cloning T4 protospacer C1 into puc19 adapted from Yaung et al. 2014 
30_Church2_top_puc19 AATTCTTCCGATCCGAAGAACTTCCAACCGGTAATGGGA top oligo for cloning T4 protospacer C2 into puc19 adapted from Yaung et al. 2014
30_Church2_bottom_puc19 AGCTTCCCATTACCGGTTGGAAGTTCTTCGGATCGGAAG bottom oligo for cloning T4 protospacer C2 into puc19 adapted from Yaung et al. 2014
30_Church3_top_Puc19 AATTCTCACGGTATGGATGCTGATGCTGAACTGTCTGGA top oligo for cloning T4 protospacer C3 into puc19 adapted from Yaung et al. 2014
30_Church3_bottom_puc19 AGCTTCCAGACAGTTCAGCATCAGCATCCATACCGTGAG bottom oligo for cloning T4 protospacer C3 into puc19 adapted from Yaung et al. 2014
Table S2.  Oligonucleotides used in this study
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CHAPTER 4: Phage predation in the human gut microbiome 
Alexandra Bryson*, Christel Chehoud*, Anatoly Dryga, Abigail Lauder, Jacque 
Young, Seth Zost, Elizabeth Loy, Eric Chen, Hongzhe Li, Richard Roberts, 
Samuel Minot, Tyson Clark, Jonas Korlach, Scott Sherrill-Mix, Frederic D. 
Bushman 
*these authors contributed equally 
4.1 Contributions 
 My contributions to this paper include the DNA modification analysis, 16S 
bacteria analysis, Jaccard analysis, gold particle staining of phage, writing the 
paper, and working with Christel Chehoud to organize qPCR, staining, and 
sequencing data collected by other coauthors. 
4.2 Abstract 
Studies of the human microbiome have specified the types of micro-
organisms present but interactions between organisms are less well studied. 
Here we report analysis of the dynamics of gut bacteriophage and their hosts in 
one healthy human male over four years of sampling.  We used multiple 
sequencing methods, including long-read single-molecule sequencing, to specify 
many of the major phage and bacterial lineages present, and their changes in 
abundance over time. RNA viruses were less common than DNA viruses and 
corresponded to probable transients in food. Analysis of single-molecule 
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sequencing data identified motif-specific covalent DNA modifications in 73% of 
phage contigs and 56% of bacterial contigs. The patterns of shared base 
modifications between phage and bacteria could be used to propose hosts for 
some of the phage studied, which allowed querying of the pairs for evidence of 
predator-prey cycles.  Assessment of viral numbers using particle counts or 
qPCR for phage genomes standardized with metagenomic data suggested 
population sizes ranging from 2.8 x 1010 to 3.7 x 1012 viral particles per gram of 
stool.   These estimates allowed investigation of predation rates--phage must 
multiply at rates that maintain the steady state density in gut despite the 
continuous outward flow of luminal contents.  Using this assumption, we were 
able to estimate predation rates ranging from 0.2% to 14% of bacteria killed by 
phage predation per day in the human gut.  Although these data emphasize that 
different approaches to estimation yield a wide range of values, we can use 
these approaches to begin to investigate the dynamics of predation in the human 
gut—for example to analyze variation among human populations, disease states, 
and responses to therapies such as antibiotics. 
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4.3 Introduction 
The composition of the human gut microbiota has now been studied 
extensively, but dynamics associated with growth and predation are much less 
well understood.  Studies of bacteria in marine and freshwater environments 
suggest that phage often outnumber their hosts, and that substantial fractions of 
the bacterial population are killed per day by phage predation(1-3).  These high 
turnover rates must have a strong effect on the composition and dynamics of 
bacterial communities, but little data is available for human gut. 
Studies of bacteriophage populations are complicated by the extremely 
high numbers and diversity of global phage populations.  Earth is believed to host 
1031 viral particles, and this is paralleled by very large numbers of viral types.  In 
contrast, the NCBI viral database only contains 6,693 reference viral genomes 
(NCBI accessed 3/10/16). Consequently, sequence samples of environmental 
viral populations typically show only modest sporadic matches to database viral 
genomes (though for viruses that are human pathogens the coverage is much 
greater).  Another challenge is that bacteriophage from vertebrate guts have 
typically proven difficult to culture outside the gut environment (4), further limiting 
experimental characterization.  
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However, it is possible to investigate bacteriophage populations in the 
vertebrate gut by purifying viral particles from stool, sequencing the encapsulated 
genomes, assembling reads to generate contigs corresponding to complete or 
partial genomes, then interrogating the contigs in longitudinal analysis.  Several 
studies have used this approach to characterize phage communities in humans 
(5-8) or reconstructed human-derived communities in gnotobiotic mice (4). 
Here we take such an approach to investigate longitudinal dynamics over 
four years in a closely-studied gut phage community from a healthy human male 
(subject 1014;(5)).  Previously viral communities were studied using Illumina 
short read sequencing over 2.5 years (5).  Here we acquired single-molecule 
sequencing data on the phage and bacterial communities, which we used to 
improve contig assembly.  The single-molecule data also allowed quantification 
of covalent DNA modification, which provide a novel means of associating 
potential phage-host pairs.  We used metagenomic sequence data, qPCR, and 
fluorescence microscopy to estimate the sizes of the phage and bacterial 
populations, and found that estimates ranged widely depending on the 
quantification methods used.  Modeling the gut as a steady state with our inferred 
phage bacterial dynamics predicts that between 0.2% and 14% of gut bacteria 
are killed per day by phage predation. 
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4.4 Results and Discussion 
4.4.1 Sequence data acquisition 
 DNA sequence data to characterize phage and bacterial communities in 
subject 1014 were derived from several sources. We previously reported phage 
contigs from 2.5 years of sampling from this subject derived from Illumina HiSeq 
short-read sequencing. We also reported deep shotgun sequence analysis for 
whole stool, allowing comparison to the full gut community.  Here we add single-
molecule sequencing data using the Pacific Biosciences technology, and further 
Illumina MiSeq sequencing of viral fractions of later time points out to 4 years.  
To characterize bacterial prey species further, whole stool DNA was also 
analyzed by PacBio sequencing, and 16S rRNA gene tag sequencing was used 
to characterize bacterial communities over the four year time span plus an 
additional year. A complete list of samples studied is in Table S1. 
For all virome samples, viral particles were purified by filtration, and 
preparations treated with nucleases to remove free nucleic acids.  Samples were 
treated with chloroform during purification, which disrupts membranes and is 
important for achieving high purity, so only non-enveloped viruses were 
recovered. We and others have observed that enveloped viruses are relatively 
uncommon in stool (5, 9, 10), so we expect only modest losses due to this step.  
Virome samples were verified to be depleted in 16S rRNA gene copies, which 
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indicates minimal bacterial DNA contamination. To characterize the RNA virome, 
RNA was purified from particles from two time points, reverse transcribed and 
analyzed by Illumina DNA sequencing.  
 
4.4.2 DNA virome contigs 
A total of 3358 contigs corresponding to DNA viruses were generated from 
the merged Illumina and PacBio sequence data (information on contigs is 
summarized in Table S2). For the merged contigs, the N50 was 25,633.  The 
maximum length was 217,304.  Contigs were aligned to viral databases, and 
16% found annotations based on matching ORFs (open reading frames) to ORFs 
of reference viral genomes.  Of these, the major groups were Siphoviridae (57%), 
Myoviridae (22%), and Podoviridae (7%).  Contigs annotated as Microviridae 
yielded large numbers of reads after GenomiPhi amplification of DNA samples, 
as expected because these small single stranded circular DNA viruses are 
preferentially amplified by this method.   
No convincing matches were detected to viruses infecting animal cells, 
though this pipeline has yielded well-known animal-cell viruses in studies of other 
sample types (11, 12). We thus infer that most or all of the contigs detected here 
likely derive from bacteriophage. 
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Many viral genomes are either circular or terminally redundant—thus an 
indication of completion of a viral contig sequence is closure of the sequence as 
a circle.  Of the 3358 contigs, 51 closed as circles.  Thus we infer that most of 
these are complete sequences, though apparent circularity could also be 
obtained if genomes contained internal direct repeats with high sequence 
identity.  The linear contigs represented either linear viral genomes or incomplete 
genomes. 
Viral ORFs were identified and the encoded proteins assessed for 
similarity to proteins of known viruses (Figure S1).  Genes commonly annotated 
as phage structural proteins (capsid, baseplate, tail, portal and others), functions 
important in nucleic acid manipulation (recombinase, resolvase, terminase, 
repressor and others), and proteins important in host cell manipulation 
(lysozyme, beta lactamases, and restriction-modification). Only 22% (2407 / 
10899) of viral ORFs found any taxonomic annotation by comparison using a 
BLAST e-value threshold of 10-5. 
4.4.3 RNA virome contigs 
Viruses containing RNA genomes were interrogated by purifying RNA 
from particle preparations from two time points, reverse transcription, and 
sequence analysis.  Reads were quality filtered and aligned to a viral database.  
The major lineages detected based on extent of coverage of the target genome 
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all annotated as Tobamoviruses, which are non-enveloped helical plant viruses.  
The Tobamovirus genus contains species such as the Tobacco mosaic virus, 
Pepper mild mottle virus, Tomato mosaic virus, and Rehmannia mosiac virus.  At 
the first time point queried (day 181), 2,768 reads aligned to Pepper mild mottle 
virus, and 545 aligned to Tomato mosaic virus.  At the second time point (day 
852), 548 reads aligned to Rehmannia mosiac virus and 862,802 aligned to 
Tomato mosaic virus.  No convincing alignments were detected to RNA viruses 
infecting human cells or RNA phage, though human RNA viruses were readily 
detected in spiked-in positive controls (data not shown).  We thus infer that the 
major RNA viruses in our fecal specimens are non-enveloped plant viruses 
ingested with food and not long term residents of the gut virome, consistent with 
published studies of other human subjects (13). 
 
4.4.4 DNA Phage populations analyzed longitudinally 
DNA Phage and bacterial contigs detected over the 4-year period of 
sampling are shown in Figure 1.  The phage populations were analyzed by 
Illumina shotgun sequencing of GenomiPhi-treated samples, so viruses with 
small, circular genomes such as Microviridae are enriched.  Many of the viral 
types detected were seen at multiple time points, suggesting stability in the major 
types present.  During the first year of sampling, one ~6 Kb contig annotating as 
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Microviridae predominated, but by day 851 this variant was replaced as the major 
form by another ~6Kb variant that could not be classified.  To evaluate stability in 
the phage population, we scored shared community membership between all 
pairwise time point comparisons using Jaccard index values. Figure S2A shows 
the Jaccard index for each pairwise comparison and indicates that community 
composition changed only slowly over the four years studied. 
Bacteria were characterized by sequencing 16S rRNA gene tags (V1V2 
region).  Overall, the predominant families were present from the start to the end 
of the study.  Prominent lineages included the Firmicutes families 
Ruminococcaceae, Lachnospiraceae, and Clostridiaceae.  Lesser amounts were 
seen for Bacteroidetes families Bacteroidaceae, Poryphoromonadaceae, and 
Prevotellaceae.  Only trace amounts of Proteobacteria were detected.  Thus the 
bacterial community is rich in anaerobes, as expected for a healthy adult (14).  
We used Jaccard index values to score shared bacterial community membership 
between all pairwise time points (Figure S2B) which suggested that shared 
community membership was generally stable but changed slowly over time. 
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4.4.5 DNA modification analyzed in phage and bacterial metagenomic 
samples 
Bacteria commonly encode nucleases targeting DNA of phage, plasmids 
and other invaders.  These include restriction enzymes (15-28), CRISPR/Cas 
systems (29-35), and other nucleases (36, 37). DNA phages recruit DNA 
modifying enzymes from their hosts to protect their DNA, so that they are 
insensitive to host nucleases, and in addition encode further modifying enzymes 
to protect their DNA.  Previous studies have specified more than ten types of 
chemical modification in phage DNA (38).  
Here we take advantage of modification patterns to propose associations 
between phage and their bacterial hosts.  In metagenomic samples, it is usually 
not possible to determine which phage infect which bacteria in the population.  
We thus sought to associate phage-host pairs in the human gut microbiome 
though matching modified motifs in our single-molecule Pacific Biosciences 
sequencing.  In this technology, single polymerase molecules traverse a single 
DNA molecule, but the presence of many forms of covalent DNA modification 
slows the kinetics, allowing modified base detection. We thus applied single-
molecule sequencing to metagenomic phage and whole stool fractions, and 
scored covalent DNA modifications common to the two, reasoning that sharing of 
patterns between phage and hosts would indicate potential phage-host pairs.  
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Single-molecule real-time sequencing has previously been used to identify 
modifications of more than 230 individual prokaryotic genomes(39) (40)--this is 
the first study to analyze paired modification profiles in bacteria and phage in 
human metagenomic samples. 
We developed a pipeline for statistical analysis of kinetic sequencing data, 
in which modified bases were scored in either motifs known to be modified from 
previous studies (41-44) or all k-mers of lengths 2-5 nucleotides.  To identify 
modified bases, we fitted a Gaussian mixture model on IPD ratio, quality score, 
and sequencing coverage.  We assumed that the IPD ratios from the modified 
bases and unmodified bases follow two separate, normal distributions.  By fitting 
the Gaussian mixture model, we obtained a posterior probability indicating how 
likely the base is to be modified.  We fitted the Gaussian mixture model for G, A, 
T, and C separately.  We compared these to a list of 467 DNA motifs previously 
known to be modified (41-44). Each nucleotide within each k-mer was analyzed 
for modification, yielding 6366 k-mer-position combinations.  The occurrences of 
each known motif and k-mer were identified in every bacterial and phage contig, 
and we recorded the mean IPD and mean posterior probability of modification for 
each motif of interest.  We used an FDR correction on the posterior probability to 
establish a list of modified motifs.  Because our method evaluates each motif 
independently on each contig, some larger k-mer motifs may show up as 
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modified because they contain an embedded smaller motif.  We thus parsed 
larger modified motifs for embedded smaller motifs within the same contig, and 
recorded the smaller motifs.  
As a control to validate our motif finding algorithm, we used a set of T4 
phage variants studied previously (45).  T4 DNA was compared containing 
glycosylated hydroxymethylcytosine T4(glc-HMC), hydroxymethylcytosine 
T4(HMC) or unmodified cytosines T4(C) (Figure S3).  In all three strains, 
adenines are methylated within GATC (A bolded to emphasize modification) 
motifs.  The GATCs in T4(glc-HMC) are know to be modified less frequently than 
T4(HMC) and T4(C)(45, 46), probably due to crowding on the DNA, and this was 
seen in results from our pipeline.  Modifications at GATC were detected in T4(C) 
and T4(HMC), but not T4(glc-HMC) because T4(glc-HMC) only modifies some 
GATC motifs and our pipeline reports motifs with complete modification.  Not 
every C in the T4(glc-HMC) and T4(HMC) appear modified by SMRT 
sequencing, so modified Cs also are not identified here.  We tested a whole 
genome amplified (WGA) version of T4(glc-HMC), which contains no DNA 
modifications and this was confirmed in our data.  
Contigs where a motif occurred at least three times were considered for 
analysis.  Of the 467 known motifs we queried, 56 were identified among 78 
phage genomes (Figure 2). Among the bacterial contigs, 1,868 had at least one 
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of 138 known motifs (Figure 3).  The bacteria and phage shared 31 known 
modified motifs.  In the k-mer analysis, 1,004 modified k-mer motifs were 
discovered in 288 phage contigs, and we observed 2,285 modified k-mer motifs 
in 2,526 bacterial contigs (Table S3).  Merging the known motif and k-mer data 
revealed that 73% of phage contigs and 56% of bacterial contigs contain fully 
modified motifs.  Table S3 contains the complete list of contigs and their 
associated modified motifs. This dataset identifies 2,804 candidate novel 
modified motifs. 
 
4.4.6 Phage-host pairs linked via DNA modifications  
We next used covalent DNA modification data to link bacteria and phage 
pairs, based on the idea that phage and bacterial DNAs in the same cell will have 
been exposed to the same DNA modifying enzymes and thus share modification 
patterns.  Overall, 443 modified motifs were shared between phage and bacteria 
(found in Table S3) suggesting many possible phage-host pairs.  Figure 4 depicts 
a subset of these possible phage-host pairs, where phage contigs were filtered 
by requiring matching to one ORF annotated as a phage protein or showing the 
top NCBI blast hit to be a phage genome.  Motifs with GATCs were removed 
from this analysis because they are widely distributed biologically and common 
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among bacteria and phage, making it difficult to determine specific phage-host 
pairs using this motif.  
Five phage contigs could be linked to bacterial contigs though five motifs 
(Figure 4). Bacteria of the Bacteriodes, Anaerostipes, and Enterococcus genera 
could be linked to specific phage contigs, as well as four unattributed bacteria.  In 
one case (CAAAAA motif) the phage motif was found in bacteria of multiple 
phyla, indicating either interphyletic mobility of restriction/modification operons or 
convergent evolution of enzyme specificities.  The CAAAAA motif has previously 
been reported modified in Clostridium difficile (47).  One of the bacterial contigs 
that contained the CAAAAA motif annotated as Lachnospiraceae, which belongs 
to the same order Clostridialese.   
For each of these pairs, we assessed possible Lotka-Volterra predator-
prey cycles in longitudinal abundance (48, 49).  In this analysis, we assumed that 
increases in predator would precede decreases on prey species, and vice versa. 
Such cycles can be observed in a plot comparing predator and prey abundances 
as a counter-clockwise progression of longitudinal samples (50). Thus we 
searched for an enrichment of left turns in the prey-predator plot. In contrast, 
reverse (clockwise) cycles have recently been proposed to occur in natural 
systems where there is co-evolutionary tradeoff of costly offense and defense 
between predator and prey (50).  
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 Samples were compared for the periods of sampling where three or more 
contiguous days were acquired, days 180-183, 851-853 and 879-883. As three 
points are required to determine turn angle, we had six total turns to compare to 
the null hypothesis of a 50% chance of a left or right turn. None of the pairs in 
Figure 4 showed such cycles. In the larger set of possible phage/host pairs, 
aggregating the bacterial data at the Family level (n=21), two examples of 
clockwise cycling were detected, and one example of counterclockwise cycling.  
However, these results are not significant after an FDR correction for multiple 
comparisons, emphasizing that future experimental designs should incorporate 
more time points and time scales of analysis.  
 
4.4.7 Dynamics of phage and bacteria in the human gut 
Given counts of phage, their hosts, and the ratio between them, then we 
can make initial estimates of the predation rate.  We thus devised two ways of 
counting phage and bacteria, and a third way of estimating the phage:host ratio 
from metagenomic sequence data.   
 In the first approach, we used quantitative PCR (qPCR) to estimate 
numbers.  DNA was purified from weighed stool samples, then 16S qPCR was 
used to measure the total numbers of bacterial 16S rRNA gene copies per gram 
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of stool. The number of cells was then inferred assuming four 16S rRNA gene 
copies per cell (51), yielding a median of 1.9 x 1013 (Table 1).   
For phage, we took advantage of qPCR analysis of phage genomes 
combined with information on the proportions of each phage in metagenomic 
data.  We devised qPCR assays for 8 phage contigs and measured the copy 
numbers in DNA from weighed stool samples (Table S4).  The total phage 
population size was then estimated by dividing the qPCR estimate by the 
proportion of the quantified phage in the metagenomic analysis of unfractionated 
stool DNA at each of three time points. All estimates were averaged to yield a 
global median of 3.7 x 1012 for the phage population size (Table 1).  
 The second method relied on classical staining of aliquots of weighed 
samples with fluorescent dyes, DAPI for bacteria and cyber gold for phage. This 
yielded 2.8 x 1011 cells for bacteria and 2.8 x 1010 particles for phage.  The 
numbers for phage reported here are ~10-fold higher than those reported 
previously by Kim et al (52). It is unknown whether this reflects a true difference 
between subjects or methodological differences.  We suspect that the cyber gold 
staining for phage undercounts particles due to inefficient staining of phage with 
smaller genomes and single stranded DNA phage.    
 We calculated the geometric mean values for phage and bacteria using 
each of the two methods, yielding phage:host ratios of 1:10 to 1.3:1 (Table 2). 
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Another estimate of the phage/host ratio could be made based solely on 
metagenomic sequence data.  As described above, we have a well-studied 
contig set describing phage in subject 1014 and shotgun metagenomic sequence 
data from unfractionated stool at three time points.  We could thus ask what 
fraction of the total metagenomic reads are contributed by sequences aligning to 
phage contigs.  We found that an average of 4% of the total reads matched 
phage contigs (range 3.5 to 4.4%).  The bacteria are estimated, on average, to 
have genome sizes 176 times longer than phage (53).  Scaling the percentage of 
reads by the ratio of genome sizes gives (0.04 phage reads)(176)=7.0 for the 
phage/host ratio (Table 2).  The proportion of phage called in the metagenomic 
ratio estimate may be high, because some of the phage sequences will be 
present as prophages in bacterial genomes. The metagenomic ratio could be low 
due to possible contamination of phage sequences with bacterial sequences, and 
also due to addition of phage not yet represented as contigs. In summary, our 
estimated phage:host ratios ranged from 1:10 to 7:1. 
  
4.4.8 Estimating the phage predation rate 
The data in Table 1 allow estimation of the rate of predation by phage on 
gut bacteria. Replication rates of phage and bacteria in gut must be matched, so 
that the population is replaced continuously despite material flowing out of the 
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gut.  To estimate predation rates, we need to know burst sizes of gut phage, and 
the rate of flow of material through the gut.  Using these data, we can estimate 
the proportion of bacteria killed per day by phage to meet the required 
replacement rate to maintain a steady state.  
From environmental data on phage replication in marine and lake 
ecosystems, the average size of a phage burst is 50 particles/burst (range 25th 
percentile 27, 75th percentile 75; Table S5).  Values for burst sizes are higher for 
laboratory measurements using bacteria grown in rich medium (170 phage per 
burst range 25th percentile 115, 75th percentile 260; Table S5), but we favor use 
of the environmental estimates for gut to reflect phage replication under non-
optimal growth conditions.  The transit time in the individual studied was 
estimated at 24 hours. 
  To estimate predation rates, we used three different values for the phage 
host ratio (Table 2).  Using targeted qPCR, we estimate that there are 8.3 x 1012 
phage and 1.6 x 1012 bacteria, though with wide confidence intervals. To produce 
this number of phage, given the average burst size of 50, 1.7 x 1011 bacteria 
must die each day.  This corresponds to 10% of all gut bacteria killed per day by 
phage predation. Using staining data, we estimate there are 2.8 x 1010 phage 
and 3.0 x 1011 bacteria (Table 2) and conclude that 0.2% of all bacteria are killed 
due to phage predation each day.  Using the metagenomic ratio of phage to 
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bacteria of 7:1, we obtain a predation rate of 14% of bacteria killed per day.  
Thus our values range from 0.2% to 14% of bacteria killed per day depending on 
the estimation method used. 
 
4.4.9 Summary and prospectus 
Here we present a four-year study of the dynamics of phage and bacterial 
populations in the gut of one adult human male.  We carried out single-molecule 
sequencing of phage and bacterial populations, augmenting a large short-read 
data set acquired previously (5), which allowed us to characterize new aspects of 
the dynamics of phage replication.  Analysis of DNA modification using the 
single-molecule sequencing data indicated that 73% of phage genomes and 56% 
of bacterial genomes were fully modified at a motif.  We expect the percent of 
modified genomes would increase if we considered motifs that are only partially 
modified.  A total of 443 modified motifs were shared between phage and 
bacteria (Table S3), suggesting potential phage:host paires, and five phage-host 
pairs could be called using conservative criteria. Predation rates could be 
assessed using data on phage and bacterial population sizes, burst sizes of 
phage in the environment, and transit time of material through the gut, leading to 
the suggestion that between 0.2 and 14% of bacteria in gut are killed by phage 
predation per day.  Several factors could have affected our estimates.  For 
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example, purification of phage particles from stool samples is unlikely to be 100% 
efficient.  It has been suggested that phage decay rates can be substantial in 
natural environments (54) —if this is true in gut, our proposed production rates 
are minimal estimates.  Conversely, it is possible that defecation and exposure of 
anaerobic bacteria to oxygen may result in phage induction and particle 
production.  If so, our measurements are overestimates. Our estimates of 
predation in gut varied associated with the method used, but all estimates 
suggested substantial predation rates.  Although methods of quantification need 
further refinement, these data pave the way for analysis of phage:host dynamics 
in medically important settings such as bacterial infections, inflammatory 
autoimmune diseases, and antibiotic use. 
 
4.5 Methods 
Research subject. This work was carried out under an IRB approved protocol 
(5). Transit time was self-reported by the research subject and parallels 
measurements with Sitz markers on healthy adults eating a high fiber diet (55). 
 
Single-molecule sequencing. For single-molecule sequencing, purified DNA 
was fragmented to an average size of 1.5 kb via adaptive focused acoustics 
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(Covaris, Woburn, MA). SMRTbell template sequencing libraries were prepared 
as previously described (5). Sequencing was carried out on an RS II (Pacific 
Biosciences, Menlo Park, CA) using P4/C2 sequencing chemistry and standard 
protocols for large insert libraries.  Consensus sequences were generated using 
Quiver. 
 
Sequencing of bacterial 16S rRNA gene tags. DNA was extracted from fecal 
samples in triplicate using the MBIO powersoil kit.  The V1V2 region of the 16S 
rRNA gene fragment was amplified using Golay-barcoded universal primes 
BSF8(27F) and BSR357(228R), listed in Table S4. The adaptors added to the 
16S specific primers allows the amplicons to be sequenced using the Illumina 
MiSeq and HiSeq platforms.   Each PCR reactions included 0.19uL of AccuPrime 
Taq DNA Polymerase High Fidelity (Thermo Fisher Scientific Inc, Waltham, MA), 
7.21 µL PCR-grade water, 2.5 µL 10X buffer II, 5 µL of each forward and reverse 
primer (2 µM), and 5 µL template DNA. PCRreactions were prepared in a PCR 
clean room. Reactions were run on an Applied Biosystems GeneAmp PCR 
System 9700 (Thermo Fisher Scientific Inc, Waltham, MA) with the following 
cycling conditions: initial denaturation at 95°C for 5 min followed by 30 cycles of 
denaturation at 95°C for 30 seconds, annealing at 56°C for 30 seconds, and 
extension at 72°C for 90 seconds, with a final extension of 8 min at 72°C. 
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Amplicions were pooled and bead purified using Agencourt AMPure XP 
(Beckman Coulter, Indianapolis, IN) with the manufacturer’s protocol. Reaction 
products were sequenced using the Illumina MiSeq technology.  The 16S rRNA 
gene reads were annotated using QIIME. 
 
Annotation of Pac Bio Sequenced Bacterial contigs. Taxonomic classification 
of bacterial contigs was performed with BROCC pipeline (56). Contigs were 
aligned against NCBI nt database with blastn program(e value = 1e-5, 
max_target_seqs = 100 and outfmt=7). BROCC then uses BLAST sequence 
alignment results for taxonomic annotation by first filtering BLAST hits for 
sufficient coverage and identity and then uses voting to classify contigs for 
required taxonomical level. Minimum coverage for the hit (min_cover) was 20% 
and minimum identity of the hit was 20% to pass quality filtering for the 
alignment. Minimum identity for classification for species and genus  levels was 
set to 60 and 40% respectively. Standard taxonomic ranks has been assigned 
with NCBI taxonomy database and are used in the further analysis. Details of the 
BROCC filtering, voting and parameters description can be found in (56) and 
source code for the BROCC pipeline is available at 
[https://github.com/kylebittinger/brocc]. 
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Matching Phage-Host Pairs by Modified Motifs.  433 motifs were shared 
between bacteria and phage contigs.  The subset shown in figure 4 was 
stringently filtered to find the best matches.  Phage contigs were required to host 
one ORF annotated as a phage protein or showing the top NCBI blast hit to be a 
phage genome.  Motifs with GATCs were removed from this analysis because 
they are widely distributed biologically and common among bacteria and phage, 
making it difficult to determine specific phage-host pairs for this motif.  Motifs 
from our list of previous known motifs that occurred at least three times within a 
contig were used in this analysis. A slightly higher cutoff of five motif occurrences 
per contig was used for k-mer motifs.  This was done to be more conservative in 
determining novel modified motifs.  Bacterial contigs were annotated with 
BROCC. 
 
Quantitative PCR. Quantitative PCR was carried out as previously described 
using the Syber green method for bacteriophage and Taqman for 16S rRNA 
genes using the primers described in Table S4.  For each amplicon, amplification 
products were cloned into bacterial plasmids and quantified for use as standards 
in the qPCR reactions. 
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Counting phage and bacteria using fluorescence staining.  Phage DNA was 
isolated from viral particles as previously described by Minot et al.(5).  
Fluorescent staining of phage particles was carried out as described in (57). 
Bacteria from stool was quantified using DAPI-staining and visualized using 
flourescent microscopy (58).  
 
Known motifs and k-mers.  Lists of modified motifs from NEB REBASE 
(http://rebase.neb.com/rebase/rebase_methylase_recseqs.txt) and R. Roberts 
(unpublished) were combined to form the known motif database.  Motifs listed as 
<genuine>y indicates modified motifs that have been experimentally validated or 
identified with high confidence through Pac Bio Sequencing.  Only motifs marked 
<genuine>y were used from this list. Another list of known motifs came from the 
NEB REBASE website in the list of all enzymes, sorted by organism 
(http://rebase.neb.com/rebase/rebase.files.html).  The motifs are listed by 
restriction recognition sites where the sequence is targeted by a 
nuclease/methylase pair. These lists were merged and redundant motifs were 
removed.  Only motifs with one modification site per motif were analyzed. 
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Statistical analysis to identify sites of modification in metagenomic data.  
We first filtered out low quality bases and contigs by 1) removing the 100 bases 
at the beginning and the end of each contig, 2) filtering out short contigs with 
length less than 1000 bp, 3) removing contigs with extreme GC content 
(GC%<15% or GC%>85%) and removing contigs with more than 50% low quality 
bases. Then we fit a Gaussian mixture model on the IPD ratio. For each base, 
there are two possible modification states, i.e. the base is either modified or 
unmodified. We assume that the IPD ratio from the modified bases and 
unmodified bases follow two separate normal distributions.  Each normal 
distribution has its own mean and standard deviation. By fitting the Gaussian 
mixture model, we obtained a posterior probability indicating how likely the base 
is to be modified. We fitted the Gaussian mixture model for A, T, C, G separately 
and the posterior probability was adjusted by FDR control.  To identify modified 
motifs, the occurrences of known motifs and k-mers were identified and recorded 
for each contig along with the median IPD and median probability of being 
modified for the base of interest within the motif.  An FDR Benjamini hochberg 
correction was applied to determine the list of modified motifs in each data set 
(phage, bacteria, or T4 strains).   
 
Contig assembly and annotation.  Three sets of contigs were combined: 1) 
117 
 
Pacific Bioscience unitigs, 2) Illumina HiSeq contigs previously published(5) and 
3) Illumina MiSeq contigs built from a single time point (10).  These contigs were 
merged using Mimimo, an overlap consensus assembler, with default 
parameters. The finalized merged contigs were annotated by length, circularity, 
open reading frames, putative viral family classification, and presence of 
integrase genes, as previously described in Chehoud et al., 2015 (10).  The viral 
contig summary and annotation is in Table S6. Bacterial contigs were annotated 
using BROCC (56). All of the bacterial genera found in the bacterial contigs by 
BROCC annotation were also identified in the 16S rRNA gene tag analysis in 
Figure 1. 
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4.6 Figures 
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Longitudinal variation in phage and bacterial communities over four years of sampling.  
A) Longitudinal abundance of phage contigs. The abundance of phage contigs is shown in 
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relative proportions over time.  The gray arrow indicates sequential days that fecal samples were 
collected.  Sample collection began on day zero and ended on day 1881. Solid lines connecting 
the plot to the sample timeline indicate time points sequenced for viral particles using shotgun 
metagenomics.  Family level classification was assigned when possible.  B) Longitudinal 
abundance of bacterial contigs. The abundance of bacterial families over time is shown in relative 
proportions.  Solid lines connecting the plot to the sample timeline indicate time points where 16s 
sequencing was done.  Family level classification was assigned using QIIME. 
Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Sites of DNA modification in phage DNA inferred from single-molecule sequencing data. 
The heat map shows the mean IPD value for individual phage contigs (rows) at the modified base 
(denoted in red) within the motifs listed in the columns.  The motifs depicted here come from the 
list of previously studied motifs. 
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Figure 3 
 
 
 
 
 
 
 
 
Figure 3. Sites of DNA modification in bacterial DNA inferred from single-molecule sequencing 
data. The heat map shows the mean IPD value for individual bacterial contigs (rows) at the 
modified base (denoted in red) within the motifs listed in the columns.  Only modified motifs that 
occurred in more than two bacterial contigs are show here.  The motifs depicted here come from 
the list of previously studied motifs. 
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Figure 4 
 
Figure 4. Associating phage host pairs via modification patterns.  Multiple modified motifs showed 
up in both the phage and bacteria data sets, which may be a way to link phage to their bacterial 
host.  Depicted here are phage contigs (containing at least one phage gene marker) that shared a 
modified motif pattern with a bacterial contig.  The lines indicated which phage contigs and 
bacteria contigs share a modified motif.  Red text indicates the predicted modified base within 
each motif. The motifs shown here have modified patterns that match between the bacteria and 
phage, and the nucleotide in red indicates where the strong IPD signal occurs and is the 
predicted modified base.  Note that strong IPD signals can occur nucleotides neighboring a 
modified bases, thus the actual modified nucleotide may occur on an adjacent base. 
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Figure S1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 1: Viral gene type composition.  The predicted ORFs in the viral contigs that 
were found any taxonomic annotation by comparison using BLAST e-value threshold of 10-5 are 
shown here grouped by gene type. 
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Figure S2 
 
Supplemental Figure 2: Shared community membership over time.  We scored shared community 
membership between all pairwise time point comparisons using Jaccard index values.  The X-
axis indicates how much time (in days) occurred between two sample time points.  At the far left 
of the graph are samples that were collected only one day apart, where as the comparisons on 
far right depict samples taken 4years apart.  A) Viral Jaccard analysis. B) Bacterial Jaccard 
analysis. 
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Figure S3 
 
Supplemental Figure 3: Analysis control of custom modified motif finder. T4 Phage T4(glc-HMC), 
T4(HMC), T4(C), and T4(WGA) have known modifications and serve as a control for our custom 
modified motif finder.  T4(glc-HMC) is methylated at GATC and C’s are modified to glucosyl 
hydroxymethylcytosine.  T4(HMC) is methylated at GATC and C’s are modified to 
hydroxymethylcytosine.  T4(C) is methylated at GATCs only.  T4(WGA) has been whole genome 
amplified from T4(glc-HMC) DNA to make an unmodified genome.  The heatmap depicts the 
mean IPD value for the modified base in the motif context denoted at the bottom of the figure.  
The rows indicate individual contigs, and the columns contain motifs that have previously been 
know to be modified in a living organism.  Our motif finding pipeline only finds motifs that are 
always modified, the GATC does not appear in the T4(glc-HMC) because it is only modified a 
fraction of the time.  The motifs depicted here come from the list of previously studied motifs. 
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4.7 Tables 
Table 1 
 
Table 2 
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Table S1 
 
 
Table S2 
 
 
Table S3 
See supplemental attachments. Modified phage and bacteria contigs.  All phage 
and bacteria contigs with modified motifs (including known motifs and kmers) are 
listed with the mean and median IPD value for each modified motif. 
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Table S4 
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Table S5 
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Table S6 
See supplemental attachments.  Merged contig summary.   
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Chapter 5: Conclusion and Future Directions 
5.1 Conclusion and Future Directions 
 This thesis sheds light on how communities of phage and bacteria interact 
through the CRISPR system and covalent DNA modifications.  In chapter 2 we 
find high nucleotide substitution rates in human gut phage over time, which may 
be in part due to CRISPR pressure(1).  In chapter 3 we explore the role of 
covalent DNA modifications in protecting phage from the CRISPR-Cas9 system.  
Specifically, we find that glc-HMC and HMC allow T4 phage to escape the 
CRISPR-Cas9 system.  In Chapter 4 we estimate phage predation rates on 
bacteria of the human gut and link potential phage-host pairs though DNA 
modification patterns.  This is the first study to look at global modification patters 
of phage and bacteria in the human gut microbiome. 
 In a 2.5 year longitudinal study of the human gut virome, we observed 
nucleotide substitution rates up to 4% in the strictly lytic ssDNA Microviridae 
phage. Phage with dsDNA genomes showed modest rates of nucleotide variation 
over time, which is consistent with temperate phage whose genomes are 
replicated by an accurate bacterial polymerases.  One possible driver for 
nucleotide changes in phage is to escape pressure from CRISPR systems(2).  
Seven bacterial contigs with CRISPR arrays targeting phage contigs were 
identified.  All but one targeted phage contained between one and four 
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protospacers, and the remaining phage contained 27 protospacers.  In one of the 
targeted phage, a  point mutation in the protospacer arose and  went to fixation 
indicating a fitness advantage for this genotype.   We also found a phage contig 
harboring a CRISPR array that targeted another phage.  There has been one 
previous report of a phage encoded CRISPR(3).  Our results suggest that both 
phage and bacteria use CRISPR systems to compete with phage. 
 Phage have been shown to use covalent DNA modifications to protect 
themselves from restriction endonucleases(4-6), however the ability of DNA 
modifications to block CRISPR nuclease activity was previously unknown.  One 
study had shown that a single adenine-N6-methyl group was not sufficient to 
block CRISPR activity(7), however phage contain multiple unique and unusual 
DNA modifications (many of which are significantly larger than methyl groups)(8).  
We used T4 phage, which replaces all of its cytosine bases with glc-HMC and 
two mutant T4 phage, which contain either HMC or unmodified C’s to further 
address this question.  Our results show that glc-HMC and HMC in high 
concentrations are sufficient to block CRISPR-Cas9 activity(9). 
In future studies I would like to test additional combinations of CRISPR 
systems and DNA modifications.  At least 16 CRISPR system subtypes and 10 
unique phage DNA modifications have been discovered(8, 10).  It is likely that 
the diverse CRISPR systems will behave differently when confronted with various 
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DNA modifications.   It is also important to establish a mechanism for how DNA 
modifications block CRISPR activity.  The in vivo assays we used could not 
distinguish if CRISPR activity is blocked at the DNA binding step or the DNA 
cleavage step.  In vitro assays with type I and type II CRISPR systems have 
been recently established and can be used to address this question.  I would also 
like to systematically test which nucleotide positions are most important in 
blocking CRISPR activity.  Crystal structures and nuclease protection assays for 
types I -III CRISPR systems indicate that the Cas proteins do not come in direct 
contact with every nucleotide in the protospacer(11-16).  Even when modified, I 
expect some nucleotides within the protospacer will not contact the Cas proteins 
and will not provide protection.  Our study uses the naturally occurring T4 
protospacers, so it was not possible to test all permutations of modified 
nucleotide positions.  However, we can use synthetic oligos and in vitro 
enzymatic assays to address this hypothesis.   
The acquisition of spacers from modified DNA is another exciting area of 
research that has yet to be addressed. I hypothesize that some DNA 
modifications can block spacer acquisition which can be tested using T4 phage 
and a genetically modified E. coli strain.  E. coli K12 contains a type I CRISPR 
system that is repressed by H-NS (heat-stable nucleoid-structure: a global 
transcriptional repressor) and LeuO(a transcription factor)(17). Knocking out H-
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NS and LeuO result in a fully functional CRISPR system.  I would culture the H-
NS and LeuO E. coli knockout with T4(glc-HMC), T4(HMC), and T4(C) 
separately and sequence the newly acquired spacers.  E. coli K12 has two 
CRISPR arrays, so I would PCR amplify both arrays and deep sequence the 
amplicons.  I anticipate spacers to be acquired without bias from the T4(C) 
infection, and the T4(HMC) and T4(gls-HMC) infections would prevent, reduce or 
bias spacer acquisition to regions of the T4 genome most devoid of modified 
bases. 
We used staining, qPCR, an metagenomics to study phage predation 
dynamics in the human gut microbiome and estimate that between 0.2 and 14% 
of the gut bacteria community are killed by phage per day.  In this study it 
became clear that each assay has advantages and disadvantages leading to an 
overall estimate with wide confidence intervals.  This suggests that current 
methods to evaluate phage and bacteria populations have significant limitations. 
Using multiple techniques to query microbial communities should be used to help 
reduce bias.   
Analysis of the gut microbiome DNA modifications indicated that 73% of 
phage genomes and 56% of bacterial genomes contain motifs that are 
completely modified.  A total of 443 modified motifs were shared between phage 
and bacteria, suggesting potential phage-host pairs, and five phage-host pairs 
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could be called using conservative criteria. The computer pipeline we developed 
is the first to query modification patters among metagenomic phage and bacterial 
communities.  The pipeline currently only identifies motifs that are modified at 
each motif occurrence.  For future directions of this project, I would like to expand 
the pipeline to identify motifs that are only modified a fraction of the time.  It is 
known that some phage modify motifs only 20-50% of the time(8).  Our pipeline 
identified modifications on all four bases (G, A, T, and C); so,  I would also like to 
use high-performance liquid chromatography coupled with mass spectrometry to 
confirm the presence of modifications on each of the bases. 
 The work in this thesis indicates that both bacteria and phage within the 
human gut microbiome use CRISPR systems to target phage.  One way phage 
may protect themselves from the CRISPR system is through covalent DNA 
modifications such as HMC and glc-HMC, so we conducted the first global 
covalent modifications analysis of bacteria and phage within the human gut 
microbiome.  We found that the majority of bacteria and phage contain modified 
motifs.  The fact that many modified motifs were shared between bacteria and 
phage highlights how important DNA modifications are to the survival of these 
intertwined communities.  This work provides insight into how phage and bacteria 
interact with each other within the human gut microbiome, a crucial step in the 
development of therapies for dysbiotic microbiomes. 
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